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Abstract 
 There is growing interest in the role of vascular disease in accelerating age-related 
decline in cerebrovascular structural and functional integrity. Since an increased 
number of older adults are surviving chronic diseases, of which cardiovascular 
disease (CVD) is prevalent, there is an urgent need to understand relationships 
between cardiovascular dysfunction and brain health. It is unclear if CVD puts the 
brains of older adults, already experiencing natural brain aging, at greater risk for 
degeneration. In this thesis, the role of CVD in accelerating brain aging is explored. 
Because physical activity is known to provide neuroprotective benefits to brains of 
older adults, the role of physical activity in mediating disease effects were also 
explored.  
 Using novel neuroimaging techniques, measures of gray matter volume and 
cerebrovascular hemodynamics were compared between groups of coronary artery 
disease patients and age-matched controls, to describe regional effects of CVD on the 
brain. In a sub-set of patients, imaging measures were repeated after completion of a 
6-month exercise training, part of a cardiac rehabilitation program, to examine 
exercise effects. Differences in cerebrovascular hemodynamics were measured as 
changes in resting cerebral blood flow (CBF) and changes in cerebrovascular 
reactivity (CVR) to hypercapnia (6% CO2) using a non-invasive perfusion magnetic 
resonance imaging technique, arterial spin labelling (ASL). We found decreased brain 
volume, CBF and CVR in several regions of the brains of coronary artery disease 
patients compared to age-matched healthy controls. The reductions in CBF and CVR 
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were independent of underlying brain atrophy, suggesting that changes in 
cerebrovascular function could precede changes in brain structure. In addition, 
increase in brain volume and CBF were observed in some regions of the brain after 
exercise training, indicating that cardiac rehabilitation programs may have 
neurorehabiliation effects as well. 
 Since, CBF measured with ASL is not the [gold] standard measure of functional 
brain activity, we examined the regional correlation of ASL-CBF to glucose 
consumption rates (CMRglc) measured with positron emission tomography (PET), a 
widely acceptable marker of brain functional activity. Simultaneous measurements of 
ASL-CBF and PET-CMRglc were performed in a separate study in a group of older 
adults with no neurological impairment. Across brain regions, ASL-CBF correlated 
well with PET-CMRglc, but variations in regional coupling were found and 
demonstrate the role of certain brain regions in maintaining higher level of functional 
organization compared to other regions.  
 In general, the results of the thesis demonstrate the impact of CVD on brain 
health, and the neurorehabiliation capacity of cardiac rehabilitation. The work 
presented also highlights the ability of novel non-invasive neuroimaging techniques 
in detecting and monitoring subtle but robust changes in the aging human brain.  
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1 CHAPTER 1 
"A good head and a good heart are always a formidable combination" Nelson Mandela 
1.1 Clinical Relevance 
 Cardiovascular disease is one of the most prevalent chronic diseases among older 
adults
1
, accounting for the second highest healthcare cost in Canada
2
. One in five 
Canadians over the age of 65 has a history of coronary artery disease (CAD), which is the 
most prevalent form of cardiovascular disease
3
. As the population of older adults 
continues to climb exponentially
4
 and the survival rate for CAD continue to increase, an 
overwhelming need to understand disease effects and improve quality of life in the 
elderly are imperative. At the societal level, age-related chronic diseases such as CAD 
pose an obvious financial and social burden, while at the individual level, the gradual loss 
of function from chronic diseases pose a threat to successful aging.  
 Rowe and Kahn defined successful aging as a combination of the ability to 
maintain a low risk for disease and disease-related disability, preserve a high mental and 
physical functional capacity and continue an active engagement in life
5
. Considerable 
efforts are being made to achieve successful aging in older adults with CAD, including 
primary and secondary interventions aimed at minimizing risks of recurrence and 
improving overall cardiovascular function
3
. However, recent evidence
6
 points to the 
possibility of comorbid neurological impairments that could threaten the mental capacity 
of CAD patients and curtail their active engagement in life.  
 It is well known that brain atrophy, cerebral hypoperfusion, white matter disease 
and impairments in cognitive function are associated with risk factors for CAD in 
asymptomatic older adults
6
. Longitudinal and epidemiological studies in individuals with 
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increased risk factors for CAD have concluded that risk factors such as hypertension, 
diabetes and high blood cholesterol advance age-related changes in the structure and 
function of the brain
7–12
. Some researchers have gone as far as suggesting that dementia, 
including Alzheimer's disease, could be associated with vascular disease, since chronic 
vascular dysfunction can limit adequate blood supply to the brain and in doing so trigger 
a cascade of events that eventually lead to neurodegeneration
13,14
. However, the direct 
impact of CAD on the structure and function of the aging brain has not yet been 
characterized. Identifying the impact of CAD on the brain could aid in devising strategies  
that facilitate successful aging in these individuals such as cognitive remediation and 
physical activity.    
 The interaction of CAD, age and cerebrovascular degeneration is complex. Non-
invasive neuroimaging techniques are crucial not only in studying this complex 
interaction, but they are becoming clinically relevant for identifying, monitoring and 
assessing clinical outcomes of CAD effects on the brain. This introductory chapter will 
define CAD, discuss concepts of normal brain aging, review premature brain aging 
associated with CAD risk factors, and discuss the role of physical activity in mediating 
successful aging. A section is also dedicated to the discussion of the brain imaging 
techniques used in this thesis to characterize CAD effects on the brain.   
 
1.2 Coronary Artery Disease 
1.2.1 Cardiovascular disease defined 
 The World Health Organisation defines cardiovascular disease as a class of 
diseases that affect the heart and blood vessels within the heart, within the brain and 
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around the body (www.who.int, Fact sheet 317). In 2009 an estimated 1.6 million 
Canadians had heart disease or stroke and 1 in 3 adults over the age of 65 were diagnosed 
with heart disease
2
. The cost of care for cardiovascular diseases in Canada was over 
$22.2 billion in 2000
2
 and is projected to rise as the number of older adults continue to 
increase
15
. Similar enormous economic burden for cardiovascular disease has been 
reported for other industrialized countries such as the United States
15,16
, Europe
15,16
, 
Australia
15
 and Japan
16
. Cardiovascular disease can be grouped into two types; 
I. Diseases due to atherosclerosis, namely, coronary artery diseases including 
myocardial infarction, cerebrovascular diseases such as stroke, and vessel 
diseases such as hypertension and peripheral vascular disease. 
II. Diseases due to damage to the heart or disorder of the heart, namely: cardiac 
arrhythmias, congestive heart failure, cardiomyopathy meaning abnormal heart 
muscle, congenital heart disease, which refers to malformation of the heart from 
birth defect, and rheumatic heart disease, which is due to damage to the heart 
muscle/valve from streptococcal bacteria
4
.  
 Atherosclerotic diseases are the most common form of cardiovascular disease, 
affecting mostly adults over the age of 65 and contributing to almost 80% of the entire 
cardiovascular disease burden
4
. Coronary artery disease, being the most prevalent form is 
an inflammatory response to atherosclerotic lesions in coronary arteries
17
. The rest of this 
section will focus on CAD and discuss the pathogenesis, risk factors, clinical presentation 
and current therapeutic interventions for CAD. First, a brief review of coronary 
circulation is presented, because abnormal circulation is a significant part of CAD 
pathophysiology. 
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1.2.2 Review of coronary circulation 
This review is culled from Principles of Anatomy and Physiology textbook by Tortora and 
Derrickson
18
 and review articles by Ramanathan and Skinner
19
, Feliciano and Henning
20
 and by 
Muller-Delp
21
. 
 All circulation to the heart comes from the aortic root, which branches out to the 
right coronary artery (RCA) and left coronary artery (LCA). The RCA and LCA run on 
the surface of the myocardium and are referred to as the epicardial or conduit vessels, as 
they offer very little resistance (5%)
20
 to coronary flow. The RCA and LCA branch out to 
more epicardial vessels that divide further into smaller branches as the vessels travel 
deeper to supply the transmural myocardium. These subendocardial vessels are the 
resistance vessels that dilate during increased myocardial oxygen demand to increase 
coronary blood flow. The RCA and branches from the RCA supply blood to the right 
atrium, right ventricle, posterior wall of left ventricle, and posterior portion of the 
interventricular septum. On the other hand, the LCA and branches from the LCA supply 
blood to the left atrium, lateral and anterior wall of left ventricle, and reminder of the 
interventricular septum. The junction at the aortic root where the coronary arteries arise 
are controlled by the aortic value which open during systole to allow blood flow to the 
systemic and central arteries, and close during diastole to allow blood flow to the 
coronary arteries. Therefore unlike all arteries in the body, which are perfused during 
systole, the coronary arteries are mostly perfused during diastole. This is because, during 
systole the contraction of heart muscles compresses the cardiac tissue including the 
subendocardial coronary arteries, and only when the heart muscle is relaxed at diastole is 
the myocardium perfused by the coronary arteries. The increased left intraventricular 
 5 
 
pressure during systole forces the aortic valve to open to the aorta while closing to the 
coronary arteries, and when the pressure in the left ventricle rapidly drops during 
diastole, the aortic valve closes to the aorta and opens to the coronary arteries. The back 
pressure from this pushes blood into the coronary arteries, perfusing the myocardium.   
 At rest, coronary blood flow is approximately 250 ml/min
19
 or 0.8ml/min/g of 
heart muscle
19
, which can increase up to fivefold during exercise. The heart extracts up to 
80% of the oxygen in arterial blood, nearly three times the amount consumed by the rest 
of the body
19
. Hence, the energy demand of the myocardium is met primarily by 
increased blood supply via vasodilation of resistance coronary vessels. The magnitude of 
the increase in coronary blood flow to accommodate increased demand is often referred 
to as coronary reserve. Coronary reserve is governed primarily by coronary vascular tone, 
which in turn is regulated by local metabolic demand, neuronal influences (sympathetic 
and parasympathetic stimulation) and flow-dependent endothelial control (figure 1.1). 
For instance, hypoxia directly triggers vasodilation of coronary arteries and also the 
accumulation of adenosine, a potent vasodilator. At rest, autoregulatory mechanisms 
maintain a constant coronary blood flow over a range of mean arterial pressures from 45 
to 150 mmHg
20
 and is essentially mediated by the same factors mentioned above that 
mediate coronary reserve. If pressure changes beyond this range, coronary blood flow 
becomes directly dependent on perfusion pressure. In general, coronary vascular tone is 
determined by the coordination of all three control mechanisms (figure 1.1 and 1.2) and 
the influence of each mechanism varies along the vascular tree. Aging can modify the 
regulation of coronary circulation inducing gradual reduction in blood flow at rest and 
with increased demand. Endothelial dysfunction, arterial stiffness and left ventricular 
 6 
 
hypertrophy are some of the age-related changes that can affect coronary circulation
22,23
. 
CAD, on the other hand, exacerbates age-related dysfunction in regulation of coronary 
circulation.   
 
Figure 1.1: Vascular disease modulation of vasodilation mechanisms of coronary 
arteries. 
 
EDRF = Endothelium-derived relaxing factor. Solid lines indicate direct influence, broken lines 
indicate secondary influence and red diagonal crosses indicates impairment of normal regulation.    
Adapted from Ramanathan and Skinner
19 
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1.2.3 CAD impairment to coronary perfusion 
 The impact of CAD on coronary circulation is significant to the function of the 
heart and equally important to the supply of blood to the brain. The brain, much like the 
heart, does not maintain a reservoir of energy substrates to help meet its energy demand. 
Hence, an increase in local metabolic demand will result in rapid hyperaemia to the 
corresponding tissue. As such, the brain and the heart are highly sensitive to insufficient 
supply of blood flow, that is, ischemia. In the heart, ischemia can be a consequence of 
narrowed vessels, referred to as coronary stenosis, or impairment in vasodilatory 
mechanisms due to atherosclerosis, diabetes or hypertension
24
. Vascular disease 
processes affect not only the vasodilation mechanisms, but they can impair the normal 
regulation of coronary circulation at rest and modulate vasoconstriction factors, as shown 
in figures 1.1 and 1.2. Atherosclerosis facilitates endothelial dysfunction by inhibiting the 
release of nitric oxide (NO)
20,21
, blunting vasodilation, and by increasing the production 
of vasoconstrictor factors such as endothelin
20,21
. Furthermore atherosclerosis can cause 
transient narrowing of coronary arteries, known as coronary spasm, by abolishing NO-
mediated vasodilation and by increasing vasomotor tone at rest
20
.   
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Figure 1.2: Vascular disease modulation of vasoconstriction mechanisms of 
coronary arteries 
 
ET-1 = Endothelin-1. Solid lines indicate direct influence, broken lines indicate secondary influence 
and red diagonal crosses indicates impairment of normal regulation. 
Adapted from Ramanathan and Skinner19 
 
1.2.4 Pathogenesis of coronary artery disease 
 Atherosclerosis is the primary cause of CAD. It often occurs within the epicardial 
coronary arteries and is viewed as an inflammatory process in response to vascular 
injury
25
. Since the mid-19th century, the accumulation of lipids in arterial wall was 
known to produce atherosclerotic lesions
25
, but the notion of vascular injury was only 
proposed in the mid 1980's
25
. Atherosclerosis is a progressive syndrome that starts off 
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with infiltration of lipoproteins in the intima of coronary arteries called fatty streaks, 
advancing to build up of lipids that adhere to smooth muscle lining forming plaques
17,25–
27
. The plaques disrupt the endothelium, finally triggering an inflammatory response to 
the fibrous caps of the plaques which then rupture and occlude vessels
17,25–27
. This 
process is complex and beyond the scope of this thesis. Below, a schematic of the 
simplified atherosclerotic process is shown in figure 1.3.  
 The common clinical outcomes of atherosclerosis in the heart include ischemia, 
tissue necrosis or myocardial infarction (MI), unstable angina, acute coronary syndrome 
and sudden death, to name a few, all of which are symptoms associated with CAD
27
. 
Typical markers of atherosclerosis include measures that detect downstream effects of 
atherosclerosis-mediated inflammation/injury such as plasma high-sensitive C-reactive 
protein (hs-CRP)
28
, interleukin-6 (due to increased level of cytokines) and tumor necrosis 
factor-α29. In addition, non-inflammatory markers associated with arterial stiffness such 
as aortic pulse wave velocity
29,30
, ankle-arm index
29
, arterial (brachial) intima media 
thickness
31
 are also usually used in assessing atherosclerosis risk and burden. 
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Figure 1.3: A concise description of the pathogenesis of atherosclerosis 
 
For detailed description consult the following references 17, 25-27. 
 
 These markers have been shown to be effective predictors of CAD
29
. 
Interestingly, recent evidence have also shown that the common carotid intima media 
thickness (CIMT) can be used as surrogate marker of generalized atherosclerosis
31,32
, and 
adding CIMT measurements to typical risk predictors can improve 10-year CAD risk 
stratification
33
. Atherosclerosis is not only significant in pathology of CAD but it is 
associated with abnormal changes in the structure and function of the brain, and will be 
discussed further in section 1.5.  
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1.2.5 Risk factors for coronary artery disease 
 Age is the most important predictor of atherosclerotic diseases. Other well known 
risk factors attributed to CAD are listed in the table 1.1
34–38
. These risk factors are used in 
identifying individuals at increased risk for CAD. In Canada, a comprehensive program 
for diagnosis and treatment of atherosclerosis disease, and prevention of cardiovascular 
disease, based on these risk factors is managed by the Canadian Cardiovascular society
34
. 
It is important to note that these risk factors are also associated with structural and 
functional impairments in brains of older adults, as will be discussed further in section 
1.5.  
 
Table 1.1: Major Risk Factors for Coronary Artery Disease 
Non-modifiable  
Age and Gender: Men ≥ 40 years old or women ≥ 50 years old 
Genetics: Family history of premature CAD in first-degree relative 
Modifiable 
Hyperlipidemia : LDL >5.0mmol/L, total cholesterol to HDL ratio > 5  
Hypertension: systolic > 140 mmHg or diastolic > 90mm Hg 
Diabetes mellitus 
Obesity and physical inactivity: increased waist circumference or BMI >27 kg/m
2
 
Evidence of atherosclerosis: hs-CRP > 2.0 mg/L 
Smoking 
Compiled from references
34–38
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1.2.6 Current therapeutic interventions 
 Interventions for CAD can be classified as either primary therapeutic and/or 
secondary preventative interventions. A list of the main current interventions and 
promising therapeutic options are listed in table 1.2. The majority of primary 
interventions are geared towards improving or restoring coronary blood flow, while 
secondary interventions are employed to minimize risks and maintain coronary function. 
A number of these interventions have been shown to interact with cerebral blood flow 
regulation or transiently affect brain functions such as cognitive processing (table 1.2). 
 
Table 1.2: Interventions employed in management of CAD 
Pharmacotherapy :can be both primary and preventative 
1. Lipid lowering and thrombolytic therapy 
a) Statins:  
 Reduction of CAD risk
39
 by inhibiting hepatic production of cholesterol, thereby 
reducing further thickening of vessel wall diameter
40,41
.  
 Reverse endothelial dysfunction in coronary vessels
40
 
 Lower levels of anti-inflammatory markers such as hs-CRP
40,41
. 
 Associated with increase in cerebral blood flow
41
 and lower risk for vascular 
dementia
41,42
.  
b) Anti-inflammatory : 
 Include antiplatelets and anticoagulants. 
 Inhibit the formation of occlusive thrombus by preventing aggregation of 
platelets
40
.   
 A notable example is salicylates such as aspirin.  
 The effect on CAD risk management is still unclear
40
.  
 Evidence of less cognitive decline in high-risk CAD patients
43
 although 
contradictory.  
2. Nitrates: Mediate release of NO and cause vasodilation, improving coronary blood flow
44
.  
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3. Antihypertensive 
a) Calcium channel blockers : 
 Used in secondary prevention of CAD
45
 
 Cause vasodilation and lower ventricular pressure load
45
 
b) Beta-blockers: 
 Used in treatment of CAD symptoms including acute coronary syndrome and stable 
angina 
 Block SNS receptors, produce positive inotropic effects (increase myocardial 
contractility) and prevent left ventricular dysfunction
46
. 
c) ACE inhibitors: 
 Reduction of MI and left ventricular dysfunction
47
.  
 Blocks angiotensin-converting enzyme (ACE) action in the renin-angiotensin-
aldosterone system
47
.  
 Treatment in hypertensive with ACE inhibitors or similar acting angiotensin receptor 
blockers have been associated with less decline in cerebral blood flow over time
48
 
and less decline in cognitive function
49
.  
 
Coronary revascularization techniques 
 Includes percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG).  
 Used in patients with unstable angina or acute MI as primary intervention to reduce the death or 
MI
50
.  
 Transient memory loss and reduction in psychomotor speed have been reported after first few 
weeks of CABG and resolves 1- 3 months after surgery
51,52
.   
 
Cardiac rehabilitation (CR): secondary prevention programs aimed at minimizing CAD risks 
include
34,53
. 
1. Smoking cessation 
2. Low sodium and sugar diet 
3. Caloric restriction 
4. Regular moderate- intensity physical activity and low-impact aerobic exercise (30-60 minutes 
most days of the week) 
54
. 
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Prescribed exercise training interventions: combine moderate-to-vigorous intensity aerobic exercise 
and resistance training as recommended by the American College of Sports Medicine and American 
Heart Association for older adults
55
. 
1. Aerobic exercise: at a frequency of 3-5 days/week and an intensity of 50-80% of exercise capacity 
lasting for a duration of 20 - 60 minutes using modalities such as walking, treadmill or cycling 
exercises
54
. 
2. Resistance exercise: at a frequency of 2-3 days/week and an intensity of 10-15 repetitions per set 
lasting a duration of 1-3 sets of 8-10 different upper and lower body exercises using modalities 
that include various forms of weight lifting and strength training
54
. 
 
Promising future interventions 
1. Genomics-based therapy: Molecular targeting of pharmacological agents to pathways associated 
with proteins that encode genes important for lipid production, to improve responsiveness. For 
instance clopidogrel is an antiplatelet being investigated in patients with genetic variants in 
cytochrome P-450, an enzyme required for metabolism of clopidogrel
56
. In these patients the 
antiplatelet effect of the drug is reduced.  
2. Stem Cell therapies: preclinical studies and clinical trials are ongoing to determine the benefit of 
stem cell therapies in improvement of cardiovascular function by replacement or repair of 
damaged cardiac tissue with progenitor cells derived from various embryonic sources
57
. Clinical 
trials have shown some reduction in death and recurrence of MI in stem cell  transplants
57
. 
However there are several challenges to this form of therapy including the potential malignant 
transformation of the cells
57
. 
 
 Cardiac rehabilitation (CR) programs are central to the management of CAD and 
involve multifaceted behavioural modification interventions aimed at reducing the risk of 
new MI or recurrence of MI after a coronary event
58
. In Canada, CR programs are largely 
hospital-based with a median duration of 5 months although home-based programs are 
also offered as an alternative. Studies have shown that the use of CR led to reductions of 
15%
58
 to 50%
59
 in mortality rates associated with cardiovascular disease. The core 
components of CR include nutritional counselling, risk factors management, psychosocial 
 15 
 
interventions and exercise training
54
. Moderate intensity exercise training is a key 
component of CR programs, and the singular effect of exercise on CAD includes, 
reduction in cardiac mortality and morbidity, reduced risk for CAD and increased 
myocardial function
60
. Even, small gains in exercise capacity of 1 ml/kg/min
-1
peak 
oxygen consumption or 1 metabolic equivalent are associated with 10% reduction in 
cardiac mortality
61
. Furthermore there is strong evidence that exercise training can reduce 
arterial stiffness in patients with CAD. A review of 5 studies relating exercise training to 
arterial stiffness in CAD patients, reported consistent findings of associations of 
improved cardiorespiratory fitness and reduced pulse wave velocity and augmentation 
index, another measure of arterial stiffness, in CAD patients after completion of exercise 
training programmes
62
. Table 1.3 adapted from the Mayo Clinic proceedings editorial by 
Franklin and McCullough
63
, highlights the therapeutic effects of regular physical activity 
on cardiovascular disease. These effect are potentially the results of improved endothelial 
function, angiogenesis, proliferation of collateral vessels and regression of coronary 
atherosclerosis following repeated bouts of exercise
64–66
. There is increasing evidence 
that suggests that moderate exercise could have neurorehabilitation effects as well. 
Section 1.6 will discuss the neuroplastic effects of aerobic exercise training in older 
adults, and in adults with increased risks for CAD. In chapters 2 and 3, the potential 
capacity of CR-based exercise programs in reversing brain abnormalities observed in 
CAD patients are demonstrated.   
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Table 1.3: Potential benefits of regular exercise for cardiovascular disease patients. 
Anti-atherosclerotic Antithrombotic Anti-ischemic Antiarrhythmic 
Improve lipids ↓ Platelet aggregation ↓Myocardial oxygen 
demand 
↑ Vagal tone 
↓Blood pressure ↓ Fibrinogen ↑ Coronary flow ↓ Adrenergic activity 
↓Adiposity ↑ Fibrinolysis ↓Endothelial 
dysfunction 
↑ HR variability 
↓ Inflammation ↓ blood viscosity ↑ Nitric oxide release  
 
Adapted from reference
63
 
 
1.3 Cerebral hemodynamics 
 Brain perfusion is tightly regulated by several complex mechanisms that ensure 
constant supply of oxygenated blood to meet the brain's energy demand. These 
mechanisms dynamically adjust cerebral blood flow (CBF) to match changes in neuronal 
activity (metabolic regulation), cerebral perfusion pressure (autoregulation), sympathetic 
nerve activation (neurogenic regulation) and/or vasoactive factors (chemoreceptor 
regulation) 
67
. Under normal conditions, the resultant flow (F) is determined by the 
differential perfusion pressure (ΔP) and resistance (R) to flow in accordance with 
Poiseuille's law
68
 (Eq. 1): 
𝐹 =  
 𝑃1 − 𝑃2 𝜋𝑟
4
8𝜇𝐿
=  
∆𝑃
𝑅
 
(1) 
Where P1 is the inflow pressure or mean arterial blood pressure, P2 is outflow pressure or 
intracranial pressure which includes central venous pressure and CSF pressure, while r, L 
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and µ describe the vessel's resistance to flow and are the radius and length of the vessel, 
and the viscosity of the fluid within the vessel, respectively. It follows that CBF is 
determined by the difference in cerebral perfusion pressure and cerebrovascular 
resistance. Such that alterations to cerebral perfusion pressure or vascular resistance 
outside the normal basal range will alter CBF levels and activate regulatory mechanisms 
to preserve constant flow. For instance, cerebral autoregulation maintains a relatively 
constant CBF over a range of mean arterial pressures from 60 to 150 mm Hg
69
. If 
perfusion pressure drops beyond the lower limit or increases above the upper limit, CBF 
will increase or decrease accordingly. All regulatory mechanisms ultimately exert their 
influence on vascular smooth muscles of the intracranial arterioles, to increase CBF by 
vasodilation or decrease CBF by vasoconstriction. The magnitude of changes in CBF, 
and to a lesser extent the corresponding blood volume, is greater during vasodilation than 
vasoconstriction
70
. As such, regional measurements of basal levels of CBF and vascular 
resistance of cerebral vessels to a vasodilatory stimuli provide crucial markers of regional 
cerebrovascular health
71–73
.  
 One of the most potent vasoactive stimuli is CO2. Increased concentration of 
blood CO2 increases partial pressure of arterial CO2 (PaCO2) and changes blood tissue 
pH, inducing relaxation of vascular smooth muscles directly or via secondary 
mechanisms that release vasoactive agents such as prostaglandins and nitric oxide
67
. 
Inhalation of CO2 can trigger changes in pH and vessel diameter within 10s and 
subsequent changes in CBF within 30s of the beginning of inhalation, with CBF reaching 
peak values around 2 min
67
. The relative increase in CBF per mm Hg increase in PaCO2 is 
around 5%/mm Hg
74
. This is illustrated in figure 1.4 showing the time courses of end-
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tidal CO2 (ETCO2), a surrogate marker of PaCO2, and CBF for a 60-year-old male 
inhaling 6% CO2for 5 min.  
 
Figure 1.4: Time courses of CBF and ETCO2 during hypercapnia. 
 
Time courses of ETCO2, total gray matter CBF and breathing rate (BR) measurements in a 60 year old 
male acquired every 15s over 13 min. Hypercapnia was induced using 6% CO2+ 21% O2+ 73% N2 for 
a duration of 5 min. Time-averaged ETCO2 for normocapnia and hypercania were 37 ± 0.8 and 51 ± 
3.8 mm Hg, respectively, corresponding to 37% increase in ETCO2 and 78% increase in CBF relative 
to baseline. Breathing rate was maintained at around 15 breaths per minute (BPM) during both capnia 
conditions using paced-breathing (metronome) to prevent hyperventilation.  
 
 This rapid response of CBF to CO2 makes cerebrovascular CO2 reactivity an 
excellent means of probing cerebral hemodynamic alterations. Cerebrovascular CO2 
reactivity (CVR) can be described as a measure of the response of the brain's 
microvasculature to CO2 stimulus, typically an elevation of arterial CO2 tension (i.e., 
hypercapnia). Hypercapnia manipulations using CO2 inhaled concentrations of 5-8% - 
resulting in an PaCO2 increase of up to 15 mm Hg -are considered safe
67
 and severe 
adverse respiratory, cardiovascular or neurological effects to short-term exposure are 
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observed at concentrations ≥10%75. Furthermore, mild hypercapnia manipulations are 
low cost, easy to implement, relatively reproducible and highly sensitive to hemodynamic 
impairments by 'steal phenomenon', where vessels that are maximally dilated will have 
reduced capacity to increase CBF
76
. However, it should be noted that the acute effect of 
mild hypercapnia on brain oxygen metabolism
77
 and neuronal activity
67
 is unclear and 
being investigated by various groups.  
 
1.4 Brain changes associated with normal aging 
 Aldred Scott Warthin (1928) described normal aging as a 'syndrome' - a complex 
period of retrogression that "consists, therefore, of a combination of organ - and tissue - 
involutions, shown histologically by well-defined tissue-lesions and manifested clinically 
by descending function-curves."
78
 This process he argues, starts gradually after 
maturation, develops throughout mid-life, accelerates by age 70 at which time tissue 
involutions start to become 'clinically apparent', and terminates in biological or 
pathological death
78
. In the brain, various studies using tissue histology and 
morphometric (CT and MRI) techniques, support Warthin's assertion of age-related tissue 
involution
79
. All structures in the brain
80
, with the exception of the brainstem
80–82
 undergo 
consistent progressive age-related involution
80
. Decline in total and regional volume have 
been reported for gray matter (GM)
83
 and white matter (WM)
79
 following maturation 
around the age of 30 years old, as well as impaired CBF
84–86
, cerebral metabolic rates of 
glucose (CMRglc)
85,87
 and oxygen (CMRO2)
85,86
. The pattern of age-related brain 
changes vary across the brain with some regions showing a linear trend, while others 
show a non-linear or curvilinear pattern, and some show preservation or delayed age 
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effect
80,88–90
. For instance, the frontal regions particularly the prefrontal, show the earliest 
and greatest loss of volume with age
79,91
, while the hippocampus and cerebral WM show 
an initial increase in volume prior to an accelerated decline much later in life
80
, which 
could signify compensation
92
, while the limbic structures show significant GM 
preservation relative to other areas
89
. This reflects the selective vulnerability of certain 
brain regions to aging, and possibly pathological effects
79
. 
 It is widely accepted that the topological pattern of normal aging follows an 
anterior-to-posterior gradient
93
, affecting first, regions that mature last during postnatal 
brain development
89
. Myelination, for instance, occurs in the cerebellum prior to the 
cerebral lobes and in the occipital prior to the frontal lobes, continuing up to fifth decade 
of life
94
. While loss of myelin sheath have been found predominantly in the anterior 
regions of the brain of older subjects compared to younger ones
95,96
. This 'last-in-first-out' 
principle, also referred to as the 'retrogenesis hypothesis'
93
 is observed in normal aging, as 
alterations in GM and WM structure
93
 and impairments in selective domains of cognitive 
function
97
.This topological pattern of normal aging is what differentiates it from 
pathological aging processes such as dementia
98–101
.The following sections will outline 
evidence of age-related retrogenesis in the brain, describe possible neurobiological 
contributions to normal brain aging, and outline effects of aging on brain function. It is 
important to note that given the large variation in study samples (age range, 
exclusion/inclusion criteria, sample size), methodology (i.e. cross-sectional or 
longitudinal), image acquisition, and image analysis techniques, comparison of 
observations among studies and overall generalization of results are limited. 
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Figure 1.5: Illustration of overt age-related brain changes seen on structural MR 
images. 
 
T1-weighted images of a young (left, 24 years old male) and older (right, 68 years old male) healthy 
participants, illustrates common differences in brain structures typically attributed to normal aging. 
Brain atrophy, sulcal widening and enlarged ventricles (shown in red arrows) are evident in the older 
brain. Images were derived from data collected as part of my thesis project. 
 
1.4.1 Evidence of age-related changes in the brain 
 Brain atrophy
100
, ventricular enlargement
102–105
 and increase in white matter 
hyperintensity
91
 are overt appearances of normal aging easily detectable in structural MR 
images, as exemplified in figure 1.5, in a young and older subject randomly selected from 
data acquired during my thesis project. On average, the total GM volume (GMV) decays 
by 2-3% per decade
105,106
, where the frontal lobe being one of the highest, decreases at a 
rate of around 5.5% per decade
107
. Reductions in GMV
87,89,90,103,104,108–110
 and cortical 
thinning
93,111,112
 related to aging are found more often in the frontal and parietal 
regions
113
, with minimal involvement of the cerebellum
82,114
, temporal lobe
113
 and 
subcortical regions including the limbic
89
 structures, and general preservation of the 
brainstem
81,82
 and occipital lobe
115
. 
 The hippocampus and entorhinal cortex known for their significance in memory 
processing
116,117
 and vulnerability to Alzheimer's disease (AD), also experience age-
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related brain atrophy
80,93,100,105,118
. However, normal aging of these medial temporal lobe 
structures are more subtle compared to the drastic changes seen in AD
93
. Their volumes 
are relatively stable throughout young adult and midlife, after which they decline 
exponentially from an annual rate of atrophy of ~0.05% in midlife to ~2% after age 60
93
. 
For comparison, the annual rate of atrophy reported for MCI and AD subjects in the 
hippocampus and entorhinal cortex are 2.39% and 3.64%, respectively
93
.  
 Likewise, deficits in WM volume also seem to appear much later in life, after the 
age of 70 and decline more rapidly than GMV
88,119,120
, following similar spatial pattern to 
GMV loss
119,121
. In healthy elderly adults, loss of WM volume is more prominent in 
prefrontal regions
118,121–123
, followed by regions within the parietal cortex
118,121
 and 
inferior temporal regions
121,123
. Furthermore, the presence of focal areas of increased 
signal intensity on T2-weighted MR images, known as white matter hyperintensities 
(WMH), are common in deep WM and periventricular WM regions of older adult 
brains
91,119,124,125
. Subcortical and periventricular WMH are prevalent after the age of 60 
years, occurring in nearly 90% and over 60% of individuals, respectively
124,125
. Although, 
the severity and extent of WMH lesions are associated with increased age
124
, and linked 
to cognitive impairments in memory
125,126
 and processing speed
126,127
, the increased risks 
for vascular disease associated with aging such as hypertension, are greater indicators of 
WMH than aging alone
125
.  
 On the other hand, results of WM microstructural integrity assessed using MRI 
measurement of WM diffusivity, such as diffusion tensor imaging (DTI), offer more 
consistent findings of age differences in WM
119
 and provide better support of the 
retrogenesis hypothesis
91,119
. Diffusion-weighted indices including fractional anisotropy 
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(FA), radial diffusivity and axial diffusivity have been used in numerous studies to 
quantify white matter structural integrity during brain development, normal aging, and in 
various disease states
128–130
. Reductions in FA could signify degradation of WM 
structure, inflammation, or loss of glial cells, while increased radial and axial diffusivities 
suggests demyelination and axonal loss or damage
128–130
. Decreased FA in older adults 
compared to younger adults have been reported primarily in anterior WM including 
unicinate fasciculus bundles of frontal WM, cingulum bundle in parietal, WM tracts in 
anterior portion of temporal lobe, but not in the inferior longitudinal fasciculus of the 
posterior temporal lobe connecting to the occipital
101,131–136
. Increased radial and axial 
diffusivities have also been found in the anterior portion of the corpus callosum 
(genu)
134,135,137
. Hasan et al. measured diffusivity in 24 WM fiber tracts in 119 healthy 
subjects from 6 to 68 years old and demonstrated a U-curve relationship between 
increasing age and radial diffusivity
138
. An initial decline in diffusivity was observed 
post-adolescence up to the age of 40, which the authors suggested was reflective of 
sustained "progressive" myelination, followed by rapid increase in diffusivity with 
advancing age, which was attributed to "regressive" and "degenerative" natural aging
138
. 
A similar but inverted U-curve was also observed in tracts measured by FA
138
.These 
diffusion-weighted MRI observations are supported by histological examinations that 
have shown myelin and axonal loss in various areas of the brains after midlife, in both 
human
95,96,139
 and animal
140
 studies. When taken together, measurements of WM macro- 
and micro-structure suggest that brain regions with recent myelination following 
maturation are more prone to age-related myelin degeneration. 
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 Similar to GM and WM structural deficits, an anterior-to-posterior gradient in 
GM hypoperfusion have be found with advancing age
8,9,86,137,141–145
, starting as early as 
20 years old and progressing steadily through middle and old age
8,9,84,86,146
, at an annual 
global rate of nearly -0.4%
137,143,144
.The greatest association with normal aging, were 
found in the frontal and parietal lobes, followed by the temporal cortex, while minimal 
relative changes are seen in the occipital or portions of the cerebellum
8,9,86,137,141–144,147
, 
even after correction for signal dilution from partial volume effects
137,142,143
. These age-
related changes in GM CBF are usually independent of underlying brain atrophy or 
cortical thinning
143
, suggesting that separate neurobiological mechanisms could mediate 
brain atrophy and cortical hypoperfusion, such as vascular aging
23,148
. Aging affects not 
only resting GM CBF, it can impair the brain's ability to respond rapidly to an increase in 
task-demand
9,86,149,150
. This is evident in reduced CVR
86,149–151
, decreased 
CMRglc
85,87,145,147,152
, and in increased oxygen extraction
85,86
 with advanced age. Lu et al 
demonstrated that age-related decline in CVR observed in the prefrontal cortex, appeared 
earlier and at a much greater rate of decay compared to CBF
86
. These age-related 
impairments in cerebrovascular hemodynamics and in metabolism of brain energy 
substrates could explain associations of aging to cognitive decline in domains of memory 
and attention
153–155
. However, age-related changes in CBF, CVR or CMRglc are 
controversial given that some studies have reported no change
156–158
 (after partial volume 
correction)
159,160
, or an increase
8
 with increase in age. Investigations of subtle change in 
CBF or CMRglc related to aging are largely limited by the ability of current imaging 
techniques to spatially resolve GM/WM-specific voxel signals and minimize partial 
volume effects
161,162
. In general, structural and functional brain changes associated with 
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normal aging are likely restricted to anterior portions of brain, areas that are involved in 
memory, executive functioning and attention. 
 
1.4.2 Neurobiology of normal brain aging 
 The neurobiological processes that mediate the structural and functional changes 
associated with age are not fully understood. Aldred Scott Warthin (1928) postulated that 
age-related changes are "…due to a loss of growth-energy, so that the cell loss exceeds 
the regenerative powers, and numerical and quantitative atrophies ensue."
78
 This speaks 
not only to changes in the brain’s energy demand and supply with age85, but also to the 
restorative or plastic capacity of the brain following age-related tissue involution
163
, as 
will be described in section 1.6. Earlier propositions suggested that normal brain aging 
was likely a result of neuronal loss
94,95,164
 secondary to cerebral hypoperfusion
141,165
 and 
subsequent hypometabolism
166
. However, recent evidence demonstrates that normal brain 
aging is more likely to arise from loss of dendrites (spine and aborization), decrease in 
synaptic pruning and alterations in neurotransmitter response over time as the brain 
struggles to maintain energy demands in the face of shrinking supply (for review see 
Dickstein et al
167
). Significant reductions in synaptic density and the number of synapses 
have been reported in the prefrontal
168–170
, superior temporal and precentral cortices
170,171
 
in older humans compared to young, and in aged nonhuman primates
172,173
, canines
174
 
and rats
175
. In addition, age-related reductions in glutamatergic
176
, serotonergic
177
 and 
cholinergic
178
neuroreceptor density and binding sites of frontal regions, along with 
reductions in myelination
95,96
, contribute to disruptions in brain signalling pathways
167
, 
which are observed as alterations in functional connectivity of frontal networks such as 
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the default mode network
179–183
. Furthermore, molecular and microvascular changes 
associated with aging including, increased oxidative stress, atherosclerotic plaque 
formation, vessel stiffness, increased arterial blood pressure, inflammation and decreased 
capillary diameter and density, contribute to the attenuation of resting CBF, and create 
impairments in cerebrovascular tone
23,148
, further limiting the brain's ability to meet 
energy demands in task-intensive regions such as in the frontal cortex. 
 
1.4.3 Effect of age on brain function 
 The cumulative effect of various changes in brain structure, metabolism and 
cerebrovascular function resulting from normal aging can impact the performance of 
cognitive function
184,185
. Poorer performance on tests for verbal fluency, visuospatial 
function, working memory, executive function and selective attention are associated with 
increased age
186,187
. Although brain regions (prefrontal, medial temporal and parietal) 
negatively associated with aging are also associated with cognitive control, evidence 
correlating cognitive decline to structural and functional decline in the these brain regions 
is limited
188
. Recent meta-analyses of 80 studies, in which brain activity was measured in 
young and old healthy adults during performance of cognitive tasks, provide a clearer 
understanding of the brain's response to normal aging
189,190
. Both reviews point to the 
compensatory mechanisms employed by the brain of older adults when engaged in 
cognitive processing
189,190
, which could be through modes of bilateral prefrontal cortex 
activation (i.e. Hemispheric Asymmetry Reduction in OLDer Adults, HAROLD) or a 
combined increase in anterior brain activity and decrease in posterior regions (i.e. 
Posterior-Anterior Shift in Aging, PASA)
185
. Compared to young adults, older adults 
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have increased activity largely in the prefrontal cortex, less activity in the occipital during 
perceptual tasks and no difference in the parietal lobe, even when performance was equal 
between groups
190
. In addition, older adults that performed better tend to have an increase 
in the left prefrontal activity while those who performed poorly activated only the right 
prefrontal
190
. These patterns of cognitive activation in old adults support views of 
increased recruitment of brain resources (HAROLD or PASA) during demanding tasks to 
maintain normal performance in the presence of structural and functional deficits
185,189
. It 
remains to be seen if over-recruitment of frontal regions in older adults is indicative of 
successful cognitive aging or a mark of inefficient activation of specialized brain 
networks (dedifferentiation)
185
. It is quite possible that compensatory activations are 
attempts at re-organizing frontal brain networks that are structurally
191
 and functionally
192
 
altered during aging. 
 
 
1.5 Brain changes associated with CAD and increased 
risk for CAD 
 "The secondary pathologic conditions that are made possible and favoured by 
primary involution process are many and of great clinical importance, because it is 
usually through some one of these that the senile individual is kept from achieving a 
biological death. They fall into several well-defined group: 1) secondary to vascular 
changes...."A S Warthin, 1928
78
. 
 The decline in regional brain structure and function in older adults with risks 
factors for CAD is greater than the decline attributed to normal aging
6
, often affecting 
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posterior brain regions and cognitive domains that are relatively stable during normal 
aging. A systematic review of neuroimaging findings from 77 studies that investigated 
brain changes related to CAD risk factors in asymptomatic individuals, concluded that 
risk factors of hypertension, type II diabetes, obesity and hyperlipidemia, independently 
contribute to adverse changes in the structure and function of the brain
6
. More 
importantly, an increase in the number of risk factors appears to increase the magnitude 
of brain changes
6
. The impact of CAD risk factors appear to be more regional than 
global
6
. In this section, evidence of regional brain atrophy, impaired hemodynamics and 
abnormal brain metabolism related to CAD and disease risk factors will be briefly 
presented.  
 
1.5.1 Changes in brain structure 
 Regional brain atrophy in the frontal, temporal and parietal gyri are associated 
with hypertension
193,194
, type II diabetes
195–197
 and obesity
6
. A voxel-based morphometry 
(VBM) study of 478 adults aged 60-64 years found an association between hypertension 
and decreased GMV in the medial frontal, superior frontal and superior temporal regions 
of male subjects, after controlling for effects of age and other vascular disease risk 
factors
194
. In another study of 134 adults from 50-70 years old, higher systolic blood 
pressure was associated with decrease in GMV in the supplementary motor area, superior 
frontal gyrus, anterior cingulate and middle temporal regions in male subjects
193
. No 
association between hypertension and brain volume were found among women subjects 
in both studies. Novak et al
197
 and Last et al
195
 reported lower GMV in the parietal and 
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occipital lobes of type II diabetics compared to non-diabetics, and more recently a VBM 
study
198
 found decreased GMV in the temporal and precentral gyri as well.   
 An increase in white matter lesions and a decrease in regional WM volume are 
associated with hypertension
199–202
and diabetes
195,197,198,200,203
. Ventricular widening have 
also been observed in hypertensive
204,205
 and diabetic
206
 patients compared to age-
matched controls. Even in earlier on in life, higher systolic blood pressure have been 
linked to white matter injury and decreased regional GMV in individuals under the age of 
50
207
. However, it appears that higher systolic blood pressure may not be associated with 
longitudinal changes in brain volume
199,208
 or in the frequency and severity of white 
matter lesions
200,202,203
. Rather, higher diastolic blood pressure in midlife are linked to 
greater longitudinal decline in GMV
208
 and increased frequency and severity of white 
matter lesions
200,202
.  
 
1.5.2 Changes in brain function 
 Individuals with uncontrolled or untreated hypertension have been shown to have 
regional hypoperfusion in the superior, inferior
209
 or and orbito-frontal cortices, anterior 
cingulate, and temporal and occipital regions compared to normotensive controls
210–213
. 
Accelerated decline in regional CBF over time has also been observed in hypertensive 
adults compared to older normotensive adults
211
 and could be linked to uncontrolled 
increases in blood pressure
48
 and increased arterial stiffness
209,214
. One study of type II 
diabetics reported reductions in CBF under resting conditions and during hypercapnia in 
the temporal and parieto-occipital regions. Although in the diabetic group, hypertension 
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was associated with lower CBF including during hypercapnia
195
. Another recent study in 
a larger cohort (541) of middle aged adults, found lower CVR in the cingulate and medial 
prefrontal lobe in individuals with elevated blood pressure compared to normotensive 
subjects, but no difference in regional CVR in individuals with elevated blood glucose or 
blood cholesterol compared to subjects with normal levels
73
. Hypertension is also 
associated with significant reductions in CMRglc in the striatum
215
 and with increased 
insulin resistance in the frontal, cingulate, parietal and temporal lobes
216
.  
 This abnormality in glucose metabolism in diabetics was linked to poor 
performance on memory tasks and an activation pattern that seem to demonstrate 
compensatory attempts during delayed recall tests
216
. Impairments in memory as well as 
in executive control, psychomotor speed and attention are reported in hypertensive 
adults
193,199,204,212
 and in individuals diagnosed with cardiovascular disease
217,218
. In 
cardiovascular disease patients, one study demonstrated accelerated decline over time in 
visuospatial skills, memory and overall cognitive function, and a linear decline in 
language, attention and psychomotor speed
217
. It is quite possible that cognitive 
dysfunctions associated with vascular disease are related to cerebral hypoperfusion and 
abnormal distribution of CBF during increased demand. For instance, in hypertensive 
subjects, decreased CBF in the superior frontal, anterior parietal and temporal was 
associated with decreased performance in attention and psychomotor processing
212
. In 
addition, during working memory tasks, hypertensive compared to normotensive subjects 
had lower increase in posterior parietal CBF
219
, displayed attempts at recruitment of other 
cortical regions, and increased contralateral flow
220
. These regional flow alterations could 
be mediated by vascular aging that are exacerbated by cardiovascular disease. Cerebral 
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hypoperfusion is linked to increased arterial stiffness
221
, and increased evidence of 
atherosclerosis
214
, and is associated with comprised neuronal viability
222
. In addition, 
higher carotid intima media thickness and increased pulse wave velocity are linked to 
poorer memory performance and lower scores on processing speed and executive 
function
218,223
. However, the pathogenesis of brain alterations associated with 
cardiovascular disease and disease risk factor are not well known. Equally, it is unclear 
what impact cardiovascular disease, specifically diseases of atherosclerotic origin such as 
CAD; have on the structural integrity and functional capacity of aging brains.  
 
1.6 The potential neuroplastic effects of aerobic 
exercise training 
1.6.1 Defining physical fitness training 
 Physical activity contributes to lower risk for CAD
53
and improves brain health 
even in late adulthood and in chronic sedentary individuals
224
. Physical activity can be 
defined as movements of the body produced by skeletal muscles that results in 
expenditure of energy
225
. Physical exercise is purposeful physical activity that is planned 
and repetitive
225
. While, physical fitness "is a set of attributes that people have or 
achieve" (Caspersen et al
225
, page 128) and can be defined as "the ability to carry out 
daily tasks with vigor and alertness, without undue fatigue and with ample energy to 
enjoy leisure-time pursuits and to meet unforeseen emergencies" (Caspersen et al
225
, page 
128). Cardiorespiratory fitness is a health-related component of physical fitness defined 
as the ability of the circulatory and respiratory systems to supply oxygen during sustained 
physical activity
225
. Individual exercise capacity and fitness level are determined 
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primarily by age, sex, exercise habit and cardiovascular health status
226
. Capacity and 
fitness level are measured using graded exercise tests such as treadmill or cycle 
ergometer, in absolute terms as metabolic equivalent of tasks (METs) meaning the 
amount of oxygen consumed at rest, where 1 METs approximates 3.5 mL of oxygen per 
kilogram of body weight per minute
226
. However, the gold standard measure of exercise 
capacity and fitness is the relative measurement of maximal oxygen consumption 
(VO2max) during dynamic exercise, a level where the greatest amount of oxygen is 
consumed despite an increasing workload
226
. For example, normal VO2max of a 50-59 
year old male is roughly 36 mL/kg/min or 10 METs
226
. The amount of VO2max in 
healthy humans is governed largely by the amount of systemic oxygen delivery to 
skeletal muscles, which is in turn, determined by the maximal cardiac output
227
. 
 The recommended form of physical fitness in older adults and adults with 
cardiovascular disease are moderate-to-vigorous intensity aerobic exercise and muscle-
strength training activities
55
. In absolute and relative terms, moderate-to-vigorous 
intensity exercises are between 3 to 6 METs
55
 or 50 to 80% of VO2max
55
 or a score of 
12-16 on the 20-scale Borg rating scale of relative perceived exertion
226
. An 
improvement in cardiorespiratory fitness by 5.4 ± 1.2 ml/kg/min
61
 or an increase of 15 to 
20%
228
 in peak oxygen consumption can be expected by cardiac patients enrolled in CR 
programs. However, perceived improvements in fitness level reported in various studies 
are difficult to compare, limited by heterogeneities in training intensities (low-moderate, 
vs. moderate-high), programme duration (4 -52 weeks), number of exercise sessions (36 
or > 36 sessions), exercise modalities (aerobic vs. mixed of aerobics and strength 
training), patient fitness level on entry and modality of fitness testing (maximal treadmill 
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or cycle ergometer vs. predictive submaximal testing including modified treadmill tests, 
or 1-mile track walk test vs. self-reported physical activity questionnaires).These 
variations in aerobic training regimen and fitness testing also limit comparisons of 
neurovascular benefits associated with aerobic exercise training. In general, 
improvements are associated with higher exercise intensity and with programs consisting 
of 36 or more sessions of aerobic-based exercise or a combination of aerobic and 
resistance training
61
. Majority of the gains in cardiorespiratory fitness are achieved in the 
first 4-12 weeks of training and little or no further increase are observed after initial 
gain
61
. Submaximal testing using graded exercise protocols with shorter stages and 
smaller transitions between workloads are preferred for testing fitness level in cardiac 
disease patients
226
.   
 
1.6.2 Effects of moderate intensity aerobic fitness training on 
brains of older adults 
 A review of studies examining the relationship between physical activity and 
brain volume in older adults outlined 9 studies where higher fitness level was associated 
with greater gray matter volumes in the anterior cingulate cortex, prefrontal, parietal and 
temporal regions, as well as the hippocampus
224,229
. Notably, Colcombe et al (2003)
230
 
showed that age-related decline in the prefrontal, parietal and temporal gray and white 
matter regions were moderated by higher aerobic fitness level. Compared to other brain 
areas, these regions also showed greater tissue preservation with increasing fitness 
level
230
, consistent with findings from other studies
224,229
. It appears that regions that 
show the greatest rate of age-related decline in brain volume discussed earlier are also the 
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regions that are highly plastic and respond more readily to modifying effects of exercise. 
In the hippocampus, for instance, a study found an annual increase in volume of 2% in 
the anterior hippocampus of aerobically trained older adults compared to an annual 
decline of 1.5% in a stretching-toning control group
231
.The increase in volume was 
associated with increased levels of serum brain-derived neurotrophic factor (BDNF) and 
improved performance in spatial memory tasks
231
. In another study, peak VO2 was 
positively associated with fractional anisotropy in the middle and posterior cingulum 
bundle
232
 and with fractional anisotropy and radial diffusivity in the body and genu of the 
corpus callosum
233
 of brains of previously sedentary older adults.  
 Likewise, increases in CBF have been found in the hippocampus
234
, anterior 
cingulate cortex
235
 and posterior cingulate/precuneus
236
 of aerobically trained older 
adults. Four months of aerobic exercise showed increased connectivity between the 
hippocampus and anterior cingulate cortex in the trained group compared to healthy 
controls
234
. Increased brain network connectivity and improved network efficiency 
between fronto-temporal regions and within the default mode network and frontal 
executive networks are also demonstrated in aerobically trained older adults
237
. In 
addition, positive correlation between aerobic fitness and task-induced activation in the 
anterior cingulate, lateral prefrontal and lateral parietal regions are evident across various 
tasks for executive function and semantic memory retrieval, potentially mediated by 
increased regional brain volume
229
. However, Colcombe et al
238
 reported decreased 
activity in the anterior cingulate, left medial frontal and middle superior temporal in 
aerobically trained older adults performing conflicting response tasks, a probe of the 
attention-driven network. This finding was attributed to improved adaptations in the 
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attention network following exercise training
238
. It is quite clear that most domains of 
cognitive control in healthy older adults benefit from physical activity, with the greatest 
improvements seen in domains of executive function, while modest improvements are 
seen on tasks of attention and spatial memory, and limited effect on tasks for working 
memory
214
.  
 In cardiovascular disease, 12-to-18 weeks of cardiac rehabilitation were 
associated with improved performance on executive function, psychomotor speed, 
attention and episodic memory tasks, and these improvements were preserved for up to 9 
months after completion of a 12-week CR program
239
. Although, there is overwhelming 
evidence of the neuro-protective and neuroplastic effects of aerobic exercise in healthy 
older adults, the benefits of aerobic exercise, alone or as part of a CR program on brain 
structure and function in cardiovascular disease patients are not well known. In fact, only 
one study to date has linked aerobic exercise-based CR programs to regional changes in 
CBF and GMV in brains of cardiovascular disease patients. In that study, MacIntosh et 
al
240
, associated gains in fitness level (VO2 peak) after 6-month CR program with 
baseline CBF in the left postcentral gyrus and baseline GM density in the right putamen. 
The effects of exercise training were not explicitly investigated. This highlights the need 
for research to investigate the neuroplastic efficacy of exercise-based CR programs.  
 It is not surprising that exercise can modify regional brain structure and cause 
selective changes in function as well. A number of studies have shown that skill training 
and learning modify structures within the adult brain
241
. Learning-induced plasticity, for 
instance, has been shown in the occipto-temporal cortex of individuals trained to 
juggle
242
. London taxi drivers were found to have larger posterior hippocampus volume 
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compared to controls and the enlargement was correlated to length of time spent driving a 
taxi cab, demonstrating the effect of navigational skill experience
243
. Interestingly, the 
effects of exercise are not only limited to motor areas, but also effects are significant in 
cognitive regions of the brain, signifying the potential salutary effects of exercise training 
in remedying pathological brain aging. It can be said that aerobic exercise training could 
potentially offer long-term neuroprotective benefits. This was demonstrated in a recent 
study where walking 72 blocks per week, equivalent to 9-15 km per week, was associated 
with greater GM volume in the inferior frontal, hippocampus and supplementary motor 
area nine years after exercise cessation
244
, and a reduced risk for developing cognitive 
impairments
244
. Meta-analyses of exercise training in older adults concluded that short-
term exercise training when used as an intervention, offered cognitive benefits in 
individuals with dementia or cognitive impairments
245
 but not in older adults free from 
cognitive impairments
246
. In all, moderate intensity aerobic exercise is sufficient to elicit 
significant changes in the structure and function of the adult brain
224
. 
 
1.6.3 Plausible neurobiological mechanisms 
 The neurobiological mechanisms of exercise-induced neuroplasticity or influence 
of exercise on cognition are unclear. Animal studies points to neurogenesis, angiogenesis, 
synaptic plasticity and upregulation of neurotrophins
247
 as possible neurobiological 
mechanisms. Rodent studies have shown that animals exposed to voluntary running have 
increased number of new neurons, spine density and higher levels of neurotophin in the 
hippocampus compared to sedentary controls, which translated into enhanced learning 
and memory for Morris water maze tasks and improved performance on avoidance 
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tasks
247
. It is more likely that exercise induces synaptogenesis rather than neurogenesis or 
true increase in neuronal volume
241
. Increased GM volumes observed post exercise 
training are likely due to expansion of the soma and nucleus of neurons and gilal cells as 
well as increased synaptic density, dendritic branching and dendrite spine proliferation
241
.  
These microstructural changes are potentially mediated by upregulation of neurotrophins 
that stimulate cell turnover and neuron proliferation including signal proteins such as 
BDNF, vascular endothelial growth factor (VEGF) and insulin-like growth factor 1 (IGF-
1)
247
. Increased concentration and expression of BDNF in the hippocampus, frontal 
cortex, striatum and cerebellum after exercise training have been observed in mice 
248
. 
When BDNF binding is blocked in mice performing water maze tasks, the effect of 
exercise is abolished
249
. Higher serum concentration of BDNF as a function of short-term 
exercise have been observed in a few studies of young adults
250
. Increased serum levels 
of BDNF have been observed in older adults after 1 year of exercise training and was 
associated with increased hippocampal volume
231
. However, there is no clear indication 
that high-intensity exercise or long-term chronic exercise have positive effects on BDNF 
levels
250
.  
 A more immediate effect of exercise is angiogenesis. Exercise is associated with 
proliferation of new vessels and increase expression of signal proteins such as VEGF and 
IGF-1 involved in production of new vessels. Exercise-induced increases in capillary 
density and VEGF transcription have been observed in the motor cortex, hippocampus, 
striatum and substantia nigra of mice brains
163
. Using magnetic resonance angiography, 
Bullitt et al
251
 demonstrated that highly fit healthy older adults had an increased number 
of small vessels compared to low fit individuals. Another recent study found increased 
 38 
 
cerebral blood volume (CBV) in the dentate gyrus of the hippocampus of young-to-
middle-aged adults after 3months of exercise training
252
. Individuals with higher VO2max 
had higher dentate gyrus CBV, but no change in performance of verbal learning (all-trial) 
or delayed recall memory tests
252
. These observations corroborated observations of 
increased CBV in dentate gyrus of adult mice that performed 2 weeks of voluntary wheel 
running compared to non-exercising controls
252
. Subsequent post-mortem studies found 
positive correlation between CBV and bromodeoxyuridine, a marker of newly born cells, 
in the dentate gyrus
252
. 
 In general, there is substantial evidence supporting the notion of exercise-induced 
proliferation of neuronal cells and increased capillary density, synaptic density and 
expression of neurotrophic factors, all of which contribute to enhanced structural integrity 
and improved brain network connectivity/function. 
 
1.7 Quantification of regional brain changes using MRI 
 This section describes the brain imaging techniques used in this thesis to measure 
differences in regional brain structure and function between coronary artery disease 
patients and age-matched controls. Regional differences in brain structure were measured 
on a voxel-by-voxel basis as local differences in gray matter density using a voxel-based 
morphometry (VBM) approach implemented in the Statistical Parametric Mapping 
(SPM) software (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/), which is described in 
the first portion of this section. Next, arterial spin labelling (ASL), a non-invasive 
perfusion MRI technique for assessment of regional differences in CBF and CVR, is 
discussed. The last portion of this section presents the rationale for the use of ASL-based 
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hemodynamic measures as suitable substitutes for established markers of brain function 
such as glucose metabolism, and introduces a study performed to investigate the regional 
correlation of CBF to cerebral glucose metabolism, which is described in detail in chapter 
4. 
1.7.1 VBM measurements of gray matter volume changes 
 VBM is an automated technique for brain segmentation and voxel-by-voxel 
comparison of local tissue (typically gray matter) concentration/volume between groups 
of subjects or against a known parameter of interest. It has been widely used in studies of 
brain atrophy in normal aging
90
 and neurodegenerative conditions
253
, as well as in 
investigations of neuroplasticity
224
. Data for VBM analysis are typically high-resolution 
(1-mm isotropic) three-dimensional T1-weighted anatomical MR images. T1-weighted 
imaging, which refers to sensitizing MR pulse sequences to the longitudinal relaxation 
time of water, is used as it is one of the primary means of generating MR contrast in 
different tissue types. In brain, good soft tissue contrast is achieved because of 
differences in the T1 values of GM, WM and CSF, which enables classification of the 
signal intensities of the various tissue types in each voxel. At a magnetic field strength of 
3T, the T1 values of GM, WM and CSF are 1445 ± 119, 791 ± 27, and 4163 ± 263 ms, 
respectively
254
.  
 At the basic level, VBM involves the registration of individual T1-weighted 
images to a common space or template, an approach known as spatial normalization, 
followed by segmentation into GM, WM and CSF tissue classes, and spatial smoothing 
of GM segments prior to voxel-wise statistical analysis
255
. The optimized VBM method 
available in SPM8 employs additional preprocessing steps to exclude non-brain voxels 
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prior to spatial normalization and subsequent segmentation
108
. It also provides options for 
computing GM volumes by scaling the voxel concentration by the amount of deformation 
estimated during spatial normalization, a process known as modulation
108
. Modulation 
compensates for the non-linear effect of spatial normalization and preserves the total 
amount of GM signal in the normalized data
108
. An extension of the optimized approach 
includes GM/WM templates generation for spatial normalization, by iterative averaging 
all subjects data using the DARTEL tool  (diffeomorphic anatomical registration using 
exponentiated Lie)
256
. 
 In SPM, image segmentation is based on a modified mixture of Gaussians where 
tissue classes (GM, WM or CSF) are modeled by Gaussian distributions of signal 
intensities combined with a priori knowledge of the spatial distribution of different 
tissues in normal subjects, derived from probability maps
257
. With this approach, each 
voxel is assigned a particular tissue class based on the maximum likelihood of belonging 
to that class. Essentially, the segmentation step generates images where each voxel has a  
posteriori probability ranging from 0 to 1. The GM/WM spatial priors are either the 
default priors derived from a standard template (ICBM-152 template, Montreal 
Neurological Institute) or study-specific, generated from averaged data of all subjects in 
the study using DARTEL
256
. The default method for spatial normalization in SPM 
registers T1 images to a standard template by minimizing the residual sum of squared 
differences between the images and the template using a 12-parameter affine 
transformation
258
. Normalization via DARTEL is highly recommended as this increases 
the accuracy of inter-subject alignment
259
, especially for older brains where atrophy can 
bias matching of T1 images to standard template
260
. In general, SPM provides a complete 
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and efficient package for measuring macroscopic differences in GM volume across brain 
regions, including generation of individual GM volumes, inter-subject alignment to a 
common space and voxel-by-voxel statistical analysis using general linear models. The 
optimized VBM approach as implemented in SPM8 was used in this thesis for 
measurement of GM volume differences. This approach is described in detail in section 
A1 of the appendix. 
 
1.7.2 Measuring cerebrovascular hemodynamics 
 The standard tool for assessments of CBF and CVR routinely in clinical practice 
is transcranial Doppler ultrasonography (TCD). However, TCD measures CBF velocity 
in large vessels, usually the middle cerebral artery, and equates blood velocity to CBF 
since the diameter of the vessel is thought to remain constant during vasoactive 
stimulation
261
. Recently, Coverdale et al
70
 demonstrated that during hypercapnia, the 
diameter of the middle cerebral artery can dilate by up to 16%, essentially 
underestimating CBF changes by 25%
261
. In addition, TCD can only provide a global 
index of changes in CBF velocity, rather than an assessment of regional CBF changes. In 
contrast to TCD, ASL measures CBF directly and can provide images across the whole 
brain
262
. Subsequent assessment of regional CVR can also be made, generally measured 
as the ratio of the change in CBF to the corresponding change in ETCO2
67
. Figure 1.6 
illustrates typical images of CVR and CBF obtained from ASL imaging from a subject. 
Hypercapnia was induced by inhaling 6% CO2 mixed in air for 5 min. However, ASL has 
inherent spatial resolution limitations that can affect regional mapping of hemodynamic 
changes at a voxel level. An alternative is BOLD functional MRI, which not only has 
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higher spatial resolution than ASL but also greater signal-to-noise ratio (SNR)
263
. 
However, the BOLD signal depends on multiple physiological parameters, CBF, CMRO2 
and CBV, which can be a confounder
263
. In addition, BOLD does not follow a linear 
relationship with ETCO2
262
, unlike ASL (CBF), which only becomes nonlinear when 
ETCO2 falls within a hypocapnic range
262,264
. 
Figure 1.6: Axial images of CBF and CVR in a single subject. 
 
Axial images of CBF at normocanpia (top row), hypercapnia (middle row) and CVR (bottom row) 
across 5 slices in the brain in a single subject. CBF and CVR measures were derived from ASL 
imaging
265
. 
 
1.7.2.1 An overview of ASL 
 Arterial spin labelling (ASL) is an MRI technique that provides the ability to 
measure CBF by manipulating the longitudinal magnetization of endogenous arterial 
blood water
266
. ASL is akin to PET-H2
15
O 
267
, the gold standard for CBF measurement, 
since both techniques use water as a flow tracer. For ASL, the flow signal is generated 
using RF pulses to invert ('label') the longitudinal magnetization of inflowing blood water 
protons in arteries. The labelled blood water flows into brain tissue, where it alters the 
local magnetization, resulting in a signal change that is proportional to CBF. A flow-
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weighted (ΔM) image is generated by subtracting the labelled image from a control 
image, which removes signal contributions from ‘static’ brain magnetization (figure 1.7).  
 
Figure 1.7: Continuous ASL label and control conditions. 
 
 
 
Perfusion-weighted (ΔM) ASL image is the difference between label images, in which the 
longitudinal magnetization of arterial blood is inverted, and control images in which the magnetization 
of arterial blood is fully relaxed.  
 
Because of the direct relationship between CBF and signal change, higher flow values 
will result in greater signal changes in the labelled image compared to the control image. 
However, due to the rapid loss of T1 label – blood T1 is approximately 1650 ms at 3T 266 
– the ASL signal decays rapidly. On the one hand, this enables serial imaging of CBF 
with temporal resolution of 5-10s, which is sufficient for capturing dynamic changes in 
CBF. On the other hand, the in-flow of labelled arterial blood only reduces the brain 
signal by approximately 1% and, therefore, multiple repetitions of label and control 
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images are acquired to improve SNR. Accurate CBF measurements are dependent on a 
number of factors including the time for labeled water to reach brain tissue, which is 
known as the arterial transit time, and labelling efficiency, which refers to the fraction of 
water magnetization that is inverted during the labelling procedure. These factors are 
discussed in the following section. 
 There are two main types of ASL labeling approaches, pulsed
268
 and 
continuous
269
. Pulsed ASL (PASL) inverts the magnetization of a large volume of 
inflowing arterial blood using a single short (5-10 ms) RF pulse, as such PASL has better 
temporal resolution and labeling efficiency, but poor SNR. Continuous ASL (CASL) 
employs long (1-3 s) RF pulses to invert inflowing spins at a single labeling plane. This 
increases SNR, but due to continuous RF pulse generation, CASL can deposit relatively 
high RF power into brain tissues. To combine the SNR of CASL and labeling efficiency 
of PASL with standard transmission RF body-coils available on all commercial MR 
scanners, a pseudo-continuous ASL (pCASL)
270
 approach was introduced. With pCASL, 
the long continuous RF pulse of CASL is replaced by a train of short RF pulses that 
mimic the adiabatic flow condition of traditional CASL, while minimizing magnetization 
transfer effects that cause large subtraction errors between the label and control 
conditions. The advantage of pCASL is it provides whole-brain coverage without the 
need for an additional labelling coil for CASL or the loss of labeling efficiencies typical 
of older labeling approach such as amplitude-modulated CASL
271
. A recent white paper 
on the implementation of ASL for clinical applications recommended the quantification 
of CBF using a simplified one-compartment flow model with pCASL imaging
266
. 
Tancredi et al
272
 demonstrated that the use of pCASL can provide more robust depiction 
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of the brain's response to hypercapnia, compared to PASL. A pCASL sequence
273
 was 
used to measure CBF in the studies described in chapters 3 and 4. 
 
1.7.2.2 Quantification of CBF using ASL 
 CBF in each voxel of pCASL images can be calculated using the standard single 
compartment tracer kinetic model as outlined in equation(2) 
273
.  
𝐶𝐵𝐹(𝑚𝑙/100𝑔/𝑚𝑖𝑛) =
6000 ∙𝜆∙𝛥𝑀∙𝑒
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2𝛼∙𝑀0 ∙𝑇1𝑏 ∙ 1−𝑒-
 −
 𝜏+𝜔 
𝑇1𝑏
 
 
,            (2) 
where Δ M is the perfusion-weighted signal, M0 is the equilibrium magnetization, which 
can be obtained from the control images or by acquiring a separate image with no 
longitudinal relaxation effects and label condition. λ is the blood/tissue water partition 
coefficient (0.9 g/mL
266), α is the labelling efficiency (85% for pCASL274 multiplied by 
94% for background suppression),τ is the label duration, and T1b is the T1 of blood 
(~1650 ms at 3T)
266. The final parameter, ω, is the post labelling delay (PLD), which 
refers to the time between the end of labeling period and image acquisition. It is included 
to enable all of the labeled water to reach the imaging volume, which minimizes the 
effects of arterial transit times
275
. This simplified model is based on the assumption that 
at the time of imaging the labelled water spins remains predominately in the 
microvasculature and decays with the T1 of blood
266
. 
 Although, the simplified one compartment model provides CBF values that 
correlate well with PET-H2
15
O measurements
267
, the model assumptions are not likely to 
be strictly true
266
. For instance, water exchange between blood and tissue in the capillary 
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bed is not quite instantaneous, rather water permeability is limited by the tight junctions 
of the blood-brain barrier
276
. However, because the T1 values of blood and grey matter 
are similar at 3T, water exchange effects have minimal effects on the ASL signal
273,276
, 
and the general view of the one-compartment model is that inherent errors from model 
assumptions are relatively small
266
.   
 
1.7.2.3 Minimizing pCASL-CBF quantification errors 
 The accuracy of ASL CBF measurements can be degraded by a number of factors, 
of which the most important is the arterial transit time. For brain, transit times are usually 
between 1 to 2s 
266
 and vary across brain regions. For instance, the longest transit times 
are found in WM, the occipital lobe and vascular border zones
277
. Transit times are 
affected by blood velocity, age, sex, and cerebrovascular disease, and prolonged times are 
associated with aging
266
 and disease
278
. Individual transit times can be measured by 
continuous sampling of inflowing blood using multiple inversions times
278
 or application 
of flow-sensitive spoiler gradients to separate vascular and tissue signal components, as 
implemented in the FEAST (flow encoding arterial spin tagging) technique
273
. However 
these efforts are time consuming and in most cases require separate CBF and transit time 
imaging. Alternatively, a PLD long enough to allow the entire tracer to reach the imaging 
plane negates the need for transit time mapping. The chosen value is set empirically 
based on the expected range of transit times within a population and SNR considerations. 
In older adults and individuals with prolonged transit times, such as in cerebrovascular 
disease, a PLD of 2s is recommended
266
. 
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 Measurable errors in CBF quantification can also be attributed to inaccurate label 
efficiency and blood T1 values. Label efficiency can be affected by flow velocity, RF 
field inhomogeneity, transit time
279
, and vessel geometry
280
. Blood T1 is dependent on 
hematocrit, temperature and blood oxygenation level, and varies with age and sex
281
. 
Label efficiency and blood T1 can be measured on each individual subject to minimize 
their effects
275
. Phase-contrast MRI can be used to measure global CBF and compared to 
whole-brain CBF values from ASL to estimate label efficiency
279
. Efficiency can be 
optimized if the labeling plane is kept at a distance of ~9 cm
279
 distal to the anterior 
commissural-posterior commissural line and slightly angled for high flow velocities (> 
55cm/s)
280,282
. Subject-specific blood T1 values can be obtained using a inversion-
recovery steady-state free precession MR imaging sequence to measure the T1 of venous 
blood
281
. 
 The SNR can be improved using techniques such as background suppression and 
retrospective correction of head motion to reduce physiological noise contributions. 
Background suppression involves the use of inversion pulses during PLD to suppress 
static brain tissue and intravascular signals. Background suppression has been shown to 
increase temporal SNR by up to 75%
283
 but induces a slight attenuation of ASL signal. 
Better SNR can also be acquired using newer fast readout approaches. ASL imaging is 
typically performed with multislice 2D echo-planar imaging (EPI) imaging; however, 3-
dimensional gradient-and-spin-echo (3D GRASE) imaging
284
 has been shown to improve 
the SNR by nearly 3 times
283
. As such, 3D GRASE pCASL images can be acquired with 
less averaging, ergo shorter acquisition times. However, 3D GRASE sequences are prone 
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to spatial blurring in the slice-encoding/ z-direction and have lower GM-to-WM CBF 
contrast ratio compared to 2D EPI readouts
283
. 
 Finally, physiological modulators of CBF such as hematocrit, caffeine, time of 
day, exercise, posture, age, sex, wakefulness and vasoactive pharmacological agents 
(indomethacin, acetazolamide) can confound hemodynamic measurements
67
. The 
influence of these factors are minimized by imaging all subjects in the same examination 
state (supine, eyes-open, caffeine- and pharmacological-free) or during post-processing 
using covariate analysis methods.    
 
1.8 Do local alterations in hemodynamics signify 
impairment in neuronal activity? 
 A long standing notion in functional imaging of neuronal activity is the close 
spatial correlation of CBF to glucose metabolism and oxygen consumption
285
, prompting 
the use of CBF as surrogate markers of function. Changes in CBF are also spatially and 
temporally correlated to neural activity
286
. Visual stimulation for instance results in an 
increase in CBF to the visual cortex, while motor stimulation produces localized 
hyperaemia in the motor cortex. Given the wide availability of MRI systems and 
relatively lower cost of performing MRI scans compared to PET, the clinical relevance of 
adopting ASL-CBF measurements as suitable makers of brain health is appealing. 
Cerebral glucose metabolism (CMRglc) measured using 
18
F-labeled fluorodeoxyglucose 
(FDG) and PET is considered the gold standard measure of brain function. Good 
agreement between regional CMRglc and regional CBF measured by PET and ASL 
respectively have been reported in healthy adults during rest
287
, and visual stimulation
286
. 
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In Alzheimer's disease patients, similar regional pattern of hypoperfusion and 
hypometabolism were observed when PET-FDG was compared to ASL-CBF
288
.  
 However, the extent of CBF and CMRglc coupling is unclear and recent evidence 
using improved ASL techniques outlined above, suggest that regional variations in 
correlation of CBF and CMRglc may exist at rest
287
. It is equally unclear if age and 
pathological disease disrupt the coupling of CBF with CMRglc. Goyal et al
85
 recently 
demonstrated that changes in CMRglc and CBF are closely matched during normal 
development, diverging over time during adulthood. In adults, changes in CBF correlated 
more with CMRO2 than CMRglc
85
. A clear pattern emerging from recent correlation 
studies, is that regions of the brain associated with higher order cognitive processing and 
perception such as the default mode network including the medial prefrontal, lateral 
temporal, posterior cingulate cortex and precueus, show the largest mismatch between 
flow and glucose metabolism
147,287,289
. Whether the flow-glucose mismatch in these 
regions are a normal variant of resting brain function is unknown. It is quite possible that 
given the significance of these brain regions in fundamental functional organization of 
the brain, these regions might retain a relatively high CBF-to-CMRglc ratio compared to 
other brain regions at rest
287,289
. It is interesting that these brain regions also have higher 
vulnerability to aging and vascular disease effects (see section on normal and 
pathological brain aging).  
 A potential source of variance in correlating regional CBF and CMRglc might be 
image registration errors. All previous comparison studies were carried out using separate 
PET and MRI scanners, requiring the need to accurately align images obtained from the 
two modalities, which were often acquired on different days. Since limitations in spatial 
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resolution occur in both modalities, errors in image alignment can increase the mismatch 
between CMRglc and CBF. Novel hybrid PET-MR imaging systems introduced in the 
last 5 years can offer insights into regional association of blood flow to brain metabolism, 
and affirm the use of ASL-CBF measures as suitable surrogate for PET-FDG in 
measurements of brain function.  
 
1.9 Thesis Outline 
 This thesis work represents a concerted effort at investigating cardiovascular 
disease contributions to pathological brain aging within a cohort of coronary artery 
disease patients, and the potential benefits of physical activity. The significance of ASL 
perfusion imaging as surrogate marker of brain function was also investigated.  
 
1.9.1  An investigation of changes in regional gray matter volume 
in cardiovascular disease patients, pre and post 
cardiovascular rehabilitation (Chapter 2).  
 Regional changes in GM volume associated with cardiovascular disease were 
assessed in coronary artery disease patients compared to age-matched controls. Evidence 
of improvements in brain structure with exercise was investigated after 6-month aerobic 
exercise training. Regional GM volume was measured using voxel-based morphometry. 
This work was published in NeuroImage Clinical, 2013; (3) 388-395 by: U. C. Anazodo, 
J.K. Shoemaker, N. Suskin, and K. S. St. Lawrence. 
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1.9.2  Impaired cerebrovascular function in coronary artery 
disease patients, and recovery following cardiac 
rehabilitation (Chapter 3). 
 Cardiovascular disease can impair the brain's hemodynamic function. To 
investigate regional changes in cerebrovascular hemodynamics, independent of 
underlying changes in brain structure. pCASL images were acquired at rest and during 
inhalation of moderate concentrations of CO2 in the same cohort of coronary artery 
disease patients and age-matched controls. Regional comparisons in CBF and CVR were 
performed at baseline between patients and control, and within a subset of patients after 6 
months of exercise training. Gray matter volume images from VBM were used as 
confounding variables to separate changes in structure from function. This work is under 
review in Journal of Cerebral Blood Flow and Metabolism [Manuscript ID: JCBFM-
0365-15], submitted by Udunna C Anazodo, J Kevin Shoemaker, Neville Suskin, Tracy 
Ssali, Danny JJ Wang, and Keith S St. Lawrence. 
 
1.9.3  Simultaneous whole-brain imaging of cerebral perfusion and 
glucose metabolism on a hybrid PET-MRI scanner (Chapter 
4) 
 In this chapter, regional association of resting CBF and CMRglc were performed 
in healthy brains of older adults, using the novel integrated PET-MRI scanner. This 
hybrid scanner allowed simultaneous imaging of ASL-CBF and PET-FDG, minimizing 
potential misalignment errors. To improve the accuracy of the PET signals measured, a 
novel method for correcting PET signal loss (attenuation) due to absorption in the body 
or scatter by MR hardware is also presented. This chapter is based on the paper entitled 
"Feasibility of simultaneous whole-brain imaging on an integrated PET-MRI system 
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using an enhanced 2-point Dixon attenuation correction method" published in Frontiers 
in Neuroscience, 2015; (8): 434, by: Udunna C Anazodo, Jonathan D Thiessen, Tracy 
Ssali, Jonathan Mandel, Matthias Günther, John Butler, William Pavlosky, Frank S Prato, 
R Terry Thompson, and Keith S St. Lawrence. 
 
1.9.4  Conclusion and Future Work (Chapter 5) 
 A summary of significant findings of the thesis are presented in this chapter. 
Clinical relevance and areas for further exploration are described.   
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2 Chapter 2 
 
An investigation of changes in regional gray matter volume in 
cardiovascular disease patients, pre and post cardiovascular 
rehabilitation. 
2.1 Introduction 
 According to the Institute of Medicine, the age standardized mortality rate from 
cardiovascular disease has declined steadily over the past 50 years in industrialized 
nations
1
. Much of the decline can be attributed to effective management of risk factors 
associated with the disease. However, in the developed world, cardiovascular disease still 
remains the most prevalent chronic disease in individuals over the age of 50, and the 
debilitating effects of the disease are evident by the high rate of hospitalization amongst 
this patient group
2
. Therefore, there is heightened urgency to understanding the impact of 
cardiovascular disease on 'successful aging', particularly given that the number of adults 
over the age of 60 is steadily increasing. 
 One growing concern is the potential link between cardiovascular disease risk 
factors and neurological impairment in older adults. Hypertension, diabetes and 
hyperlipidemia have been independently linked to abnormal changes in morphology and 
function of the aging brain
3
. Older individuals with higher estimated risk of coronary 
artery disease (CAD) tend to have decreased brain volume, cerebral blood flow, and 
glucose metabolism in regions of the brain associated with cognitive function and, as 
such, are at a greater risk of dementia
3
. Even in older adults with no clinical diagnosis of 
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cardiovascular disease, decline in cardiac function is associated with deficits in cognitive 
function
4
, brain atrophy
5
 and white matter hyperintensity
6
. 
 Despite the above studies involving cardiovascular risk factors, there have been 
no similar studies on the impact of cardiovascular disease, more specifically CAD, on 
normal age-related changes in regional brain morphology. Coronary artery disease is the 
most common form of cardiovascular disease in adults over 50 years old with known 
pathophysiology
7
 and effective management strategies
8
. Physical activity is one of the 
most powerful and readily available interventions with proven efficacy in preventing 
secondary CAD. Physical activity, specifically aerobic fitness has been shown to improve 
coronary flow, lower the risk of myocardial reinfarction, lower mortality rates, and 
improve overall cardiac function
9
. Consequently, increased levels of physical activity are 
increasingly prescribed as part of the clinical management for CAD
10
. In older adults, 
physical activity has also been associated with improved cognitive function
11
, decreased 
risk for dementia
12
 and reversal of cortical decline
13
. 
 These observations highlight the need to investigate the association between CAD 
and brain structure and whether interventions, such as physical activity, can reverse any 
adverse disease-related effects. The objectives of this study were twofold: 1) to 
investigate potential differences in regional gray matter volume in patients recently 
diagnosed with CAD compared to controls, and 2) to determine if a standard cardiac 
rehabilitation regimen would reverse CAD-related structural changes.  
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2.2 Methods 
2.2.1 Participants 
 This study was approved by the Western University Health Sciences Research 
Ethics Board, and written informed consent was obtained from all subjects. CAD patients 
were recruited from the London Health Sciences Centre for Cardiac Rehabilitation and 
Secondary Prevention program following recent diagnosis of one of the following: acute 
coronary syndrome (ST elevation or non-ST elevation myocardial infarct), angina, 
percutaneous coronary intervention, or coronary artery bypass surgery. Patients were 
excluded if they had congenital coronary abnormality, cardiomyopathy, severe 
congestive heart failure, second or third-degree atrioventricular block, more than two 
myocaridal infarcts, sick sinus syndrome, or major arrythmias. Patients with uncontrolled 
hypertension or a history of diabetes for more than 5 years were also excluded. Age-
matched control subjects included in this study had no clinical diagnosis of 
cardiovascular disease, were non-smokers, and did not have hypertension or diabetes. 
Both patients and controls were free of any neurological condition or disease.  
 
2.2.2 Clinical assessments of health 
 The relevant clinical markers of CAD measured in all subjects are described 
below. A standard three-lead electrocardiogram was conducted after 20 minutes of supine 
rest. Blood pressure was continuously measured during electrocardiogram using a 
Finometer, which was calibrated against periodic sphygmomanometric measurements 
(Dinamp, GE Healthcare, Finland). Blood-borne markers of vascular disease namely; 
plasma lipids, cholesterol, high-sensitivity C-reactive protein (hs-CRP) and glucose, were 
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collected under fasting conditions. A Doppler echocardiography (GE/Vingmed System 
FiVe Doppler) was completed prior to cardio-respiratory exercise stress testing to assess 
left ventricular ejection fraction, left ventricular mass and left ventricular contractility. A 
test of global or overall cognitive function was performed with the Montreal Cognitive 
Assessment, MoCA (http://www.mocatest.org/). Cardiorespiratory fitness was measured 
by a graded exercise test in which subjects were tested to volitional exhaustion under 
standard clincial observation (ACSM 1995)
14
. Breath-by-breath measurements of oxygen 
consumption (VO2), heart rate and blood pressure were recorded throughout the test. 
Maximal oxygen consumption (VO2max) is an established marker of cardiorespiratory 
fitness and a clinically accepted surrogate maker for left ventricular function
15
. Each 
subject's VO2max was estimated from the graded exercise test.  
 
2.2.3 Clinical assessments of cardiac rehabilitation 
 The aerobic exercise component of the cardiac rehabiliation (CR) program was 
performed according to current guidelines
16
 at an intensity of  40-70%  of  heart rate 
reserve (i.e., the difference  between  the  age-predicted  maximum and  resting heart 
rates)
17
, or at a rate corresponding to an exertion score of 11-14 on the Borg scale
18
. 
Aerobic exercise was performed a minimum of 3 days per week at a duration of  20-to-30 
minutes per session. 
 
2.2.4 MRI data acquisition 
 Whole-brain MRI images were acquired on two Siemens 3T MAGNETOM
® 
Verio systems (Siemens  Medical  Systems,  Erlangen,  Germany) equipped  with 32-
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channel head array coils. Sagittal T1-weighted images were acquired on each subject for 
gray matter volumetric analysis using a three-dimensional (3D) magnetization-prepared 
rapid gradient-echo imaging sequence (isotropic voxel resolution=1.0mm
3
; repetition 
time, echo time and inversion time = 2000, 2.98 and 900ms, respectively; acceleration 
factor = 3; and flip angle=9 degrees). 
 
2.2.5 Voxel-based morphometery analysis 
2.2.5.1 Effects of disease 
 T1-weighted images were segmented into gray matter (GM), white matter (WM) 
and cerebrospinal fluid (CSF) using the segmentation option in SPM8 
(http://www.fil.ion.ucl.ac.uk). The tissue segments were then affine-registered to their 
respective Montreal Neurological Institute (MNI) tissue probability maps, averaged and 
smoothed with a 12-mm filter using DARTEL to create a study-specific template
19
. The 
individual GM images were spatially normalized to this template using a high-
dimensional DARTEL registration and then multiplied by the Jacobian determinant (i.e., 
modulation) to correct for nonlinear differences in individual brain size. Finally, the GM 
images were smoothed with an 8-mm Gaussian filter. Local differences in GM volume 
(GMV) between groups were investigated with a gender-by-group two-factor analysis of 
variance, performed on the smoothed GMV images. An absolute threshold mask set at 
0.1 was used to remove non-GM and extra-cranial effects. A significant positive effect of 
disease was identified at voxel levels that differed between groups at p<0.05 after 
correction for multiple comparisons using the false discovery rate (FDR)
20
. 
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2.2.5.2 Effects of Rehabilitation: 
 Pre and post CR T1-weighted images of the CAD patients were analyzed with the 
default options of the longitudinal module found in the VBM8 toolbox of SPM8. Briefly, 
each subject's data were analyzed in a series of steps that included; 1) intra-subject 
registration, 2) intra-subject bias correction, 3) segmentation, 4) non-linear DARTEL 
registration to study-specific template, 5) modulation of GM segments, and 6) spatial 
smoothing with an 8mm Gaussian filter. A repeated measures analysis of variance of the 
change in GM volume over time was performed on the smoothed GM image with a 
within-subject factor of time and between-subject factor of scanner. Gender-by-time 
analysis of variance was also explored. A positive significant change was identified at 
voxel levels that showed positive change in volume for p<0.05 after correction for 
multiple comparisons using the more stringent family wise error (FWE). An absolute 
threshold mask was also set at 0.1.  
 To investigate evidence of GMV recovery with CR, binary masks of regions of 
interests (ROIs) were created using the MarsBaR ROI toolbox 
(http://marsbar.sourceforge.net) from clusters of voxels that showed statistically 
significant decline in GMV in the CAD group compared to controls (see table 2.2) with 
minimum voxel clusters of 50 contiguous voxels. Small volume correction was 
performed in SPM8 on contrast images from the repeated analysis of variance with the 
ROIs to restrict multiple comparisons to a smaller number of voxels, which reduced type 
II errors. Areas of GM recovery are reported as significant if clusters survive FWE 
correction at p<0.05. 
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2.2.6 Statistical analysis 
 Statistical analyses were conducted with SPSS 20.0 statistical software (IBM 
Corp. Armonk, NY, and USA). Clincal assesments from the control group was compared 
to baseline data from the CAD patient group using a one-way multivariate analysis of 
variance to test for differences in cardiovascular health and cognitive function. Clinical 
parameters entered into the multivariate analysis for cardiovascular health include all 
variables listed in Table 2.1 except for age, gender, MoCA and VO2max. Gender 
differences between groups was assessed by gender-by-group interaction and simple 
main effects of gender. Significant interaction and main effects are reported at p <0.05. 
Spearman rank correlation analysis was performed between baseline total gray 
matter/ROI volumes and baseline MoCA scores, VO2max and other clinical measures 
collected to investigate the association between overall cogniton, fitness level, 
cardiovascular health, and brain atrophy. Total gray matter volume in mm
3
 for each 
subject was obtained from the VBM8 segmentation output, while mean values of regional 
gray matter volume were extracted from voxel clusters that showed significant difference 
between groups for each subject using MarsBaR, as described earlier. 
 A paired t-test was conducted on the clinical variables collected on the CAD 
patients pre and post CR to test for a difference between the means (p<0.05). To test for 
association between fitness level and GMV post CR, a Spearman rank correlation 
analysis was performed between VO2max and total gray matter/ROI volumes obtained 
from post CR data, and between change in GMV and change in VO2max post CR.  
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2.3 Results 
2.3.1 Cardiovascular disease effects 
 A total of 41 CAD patients and 21 controls participated in the study; their 
characteristics are provided in Table 2.1. Data from three controls and two CAD patients 
data were removed because of neurological incidental findings in the MRI data. Data 
from 36 patients and all controls were collected on one scanner, while data from the last 5 
patients were acquired on a separate, but identical, scanner during the upgrade of the first 
one. All control subjects and 18 CAD patients completed the graded exercise testing with 
cardiorespiratory measures to maximum volitional exhaustion to establish maximal 
oxygen uptake (VO2max). 
 The CAD group comprised of patients with clinical diagnosis at referral of angina 
(12.1%), myocardial infract (12.1%) and coronary artery disease (69.7%). All patients 
were on a combination of drug therapy and 36.8% had percutaneous coronary 
intervention while 7.9% received coronary artery bypass grafting. Drug therapy included 
cholesterol lowering/statins (87.2%), beta-blockers (76.9%), ACE-inhibitors/Angiotensin 
II receptor blockers (56.4%) and anti-platelets including aspirin (84.6%). There were no 
significant interactions between gender and group for any of the clinical measures, 
including markers of fitness. No significant differences between patients and controls 
were found for measures of blood pressure, cardiac output, left ventricular ejection 
fraction, resting heart rate and blood glucose. However, compared to control, CAD 
patients had lower MOCA scores (F =4.3 (1,53), p< 0.05), lower VO2max (F = 17.04 
(1,53), p< 0.001), lower total cholesterol levels (F = 16.22 (1,56), p< 0.001), elevated 
body mass index, BMI (F = 17.86 (1,56), p<0.001), and increased  hs-CRP levels (F = 
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7.40 (1,55), p< 0.01). There was also significant difference in level of education (p 
=0.031), as defined by the number of years of formal education, between patients (15.5 ± 
2.7 years) and controls (18.3 ± 4.3 years). 
 
 
Table 2.1: Study participant characteristics. The mean and standard deviation are 
presented for clinical variables measured at baseline in CAD patients and controls. 
Variable Controls (n=21) Pre-CR CAD patients (n=39) 
Age 59  ± 8 59 ± 7 
Gender (men/women) 11/10 28/11 
BMI 24.8  ± 3.3 29.8  ± 4.7
a
 
Fasting blood glucose (mmol/L) 4.75  ± 0.88 5.23  ± 1.32 
Total cholesterol (mmol/L) 4.17  ± 0.94 3.16  ± 0.79
a 
hs-CRP (mg/l) 0.95 ± 0.89 2.25  ± 3.10
a
 
Rest supine systolic blood pressure 
(mmHg) 
121 ± 16 127 ± 22 
Rest supine diastolic blood pressure 
(mmHg) 
69 ± 8 71 ± 12 
Left ventricular ejection fraction (%) 68  ± 9 64  ± 8 
Resting heart rate (beats per minute) 59 ± 10 59 ± 7 
MoCA 28.16 ± 1.7 26.86 ± 2.1
a 
VO2max (mL/min/kg) 37±2 26±2
a 
 a = Statistical difference between groups at p<0.05 
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  VBM results of regional GMV differences between patients and controls 
are shown in Figure 2.1, and the corresponding MNI coordinates and Talairach 
anatomical labels are listed in Table 2.2. In general, the CAD patient group exhibited 
significantly lower GMV in the frontal lobe, parietal lobe, temporal lobe, and cerebellum. 
There was a significant difference in total GMV (F = 5.5 (1, 53), p< 0.05) between 
groups but no statistical difference in total intracranial volume. There were moderate 
positive associations between VO2max and total GMV (ρ = 0.420 (38), p< 0.001), and 
GMV in the left posterior cerebellum (ρ = 0.616 (38), p<0.001) and right post central 
gyrus (ρ =0.403 (38), p<0.01). There was no significant gender-by-group interaction, nor 
was there any correlation between total/regional GMV and MoCA scores or any other 
clinical parameter measured. Repeating the VBM analysis after removing the data from 
the 5 patients acquired on the second system had no effect on these results, except to 
reduce the effect size of the observed regional changes by 5 ± 13%. 
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Figure 2.1: Differences in GMV between CAD patients and age-matched controls 
measured at baseline. 
 
t-statistics displayed on a rendered model of a single subject brain. The red blobs on coronal, sagittal 
and transverse planes indicate areas of decreased GMV in the CAD patient group. 
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Table 2.2: Local maxima of clusters of significant change in GM volume in the pre-
CR CAD patient group compared to controls. 
Cluster 
Number 
Volume (mm) Anatomical label 
Brodmann 
Area 
MNI 
Coordinate 
x        y      z 
t-
value 
1 2688 
L superior frontal gyrus 
L superior frontal 
L medial frontal 
10 
10 
11 
-22 
-18 
-27 
57 
55 
45 
-10 
-23 
-6 
5.03 
3.00 
4.66 
2 1831 
R superior frontal gyrus 
L frontal lobe (rectal gyrus) 
R superior frontal 
10 
11 
10 
18 
0 
14 
58 
48 
54 
-10 
-23 
-15 
4.96 
4.76 
3.81 
3 1515 L posterior cerebellum  NA -40 -68 -12 4.90 
4 510 R posterior cerebellum NA 3 -73 -3 4.73 
5 799 
R medial frontal gyrus 
L medial frontal gyrus 
9 
8 
9 
-6 
47 
45 
29 
29 
4.64 
3.74 
6 674 R inferior frontal gyrus 47 42 15 -3 4.52 
7 977 
L parietal lobe (post central 
gyrus) 
L Frontal (precentral gyrus) 
40 
4 
-56 
-51 
-20 
-13 
19 
42 
4.42 
3.74 
8 202 
L inferior frontal gyrus 
L parietal (precentral) 
44 
4 
-53 
52 
4 
-5 
16 
15 
4.41 
3.50 
9 774 R orbitofrontal 11 22 38 -22 4.33 
10 1601 
L Inferior frontal gyrus 
L Insula 
47 
 
-42 
-33 
28 
17 
-1 
0 
4.31 
4.01 
11 134 L inferior parietal gyrus 40 -42 -36 41 4.13 
12 518 R inferior parietal lobe 40 51 -33 40 4.07 
13 83 L middle temporal gyrus 37 -51 -55 0 4.02 
14 127 R superior parietal gyrus 7 24 -58 61 3.96 
15 141 L temporal lobe (Fusiform) 37 -50 -42 -10 3.71 
16 270 L superior temporal gyrus 38 -33 5 -17 3.63 
17 50 R superior temporal gyrus 38 44 3 -19 3.50 
18 69 R inferior temporal gyrus 20 39 -22 -31 3.45 
19 74 
R anterior cingulate gyrus 
(dorsolateral) 
32 6 25 30 3.38 
Coordinates are given in anatomical MNI space and maxima are shown at least 8.0 mm apart. The 
center of mass of each ROI is shown in bold. L = left; R = right. 
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2.3.2 Effects of cardiac rehabilitation 
 Twenty-four CAD patients (18 men and 6 women) completed the 6-month CR 
program and post-CR testing. The MRI data, pre and post rehabilitation, from the last 
five patients were acquired on the second scanner. Fifteen patients completed graded 
exercise testing to maximum volitional exhaustion on entry and exit from the CR 
program. No statistically significant differences were found in any of the clinical 
parameters between the pre and post CR tests. In addition, there was no change in MoCA 
scores (p =0.3) after 6 months of CR. There was a trend (5%) towards increased VO2max 
(p=0.06) in the 15 patients tested after 6 months of CR.  
 Regions of positive change in GMV from VBM analysis of CAD patients, pre and 
post CR, are listed in Table 2.3 and displayed on Figure 2.2. The main increases in GMV 
after 6 months of CR were observed bilaterally in the frontal lobe, middle temporal gyrus 
and supplementary motor area (Table 2.3). Small clusters of increase in GMV were 
observed in some of the regions affected by CAD (see Table 2.4), signifying a recovery 
of volume following CR. There was no change in total GMV or total intracranial volume 
after CR. No significant correlation was found between VO2max post CR and regional 
GMV and between change in VO2max and regional increase in GMV. There was no 
significant scanner-by-time interaction or gender-by-time interaction (p<0.05, FWE) and 
no difference in GMV or clinical measures between patients that successfully completed 
exercise testing and patients that were unable to.  
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Figure 2.2: GMV changes over time in CAD patient pre and post CR. 
 
t-static displayed on a rendered model of a single subject brain. Red blobs on coronal, sagittal and 
transverse planes indicate areas of increased GMV in the CAD group after 6 months of CR. 
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Table 2.3: Local maxima of clusters of significant change in GM volume in the CAD 
post CR (Post >Pre). 
Cluster 
Number 
Volume 
(mm) 
Anatomical label 
Brodmann 
Area 
MNI Coordinate 
x        y      z 
t-value 
1 1095 Right frontal(paracentral) lobe 6 8 -33 66 13.67 
2 304 Left middle temporal gyrus 21 -62 -60 9 11.63 
3 504 Left frontal (paracentral) lobe 6 -8 -28 66 10.70 
4 782 
Right anterior cerebellum 
Left posterior cerebellum 
Left cerebellum 
NA 
NA 
NA 
3 
0 
-8 
-55 
-73 
-81 
4 
-8 
-15 
10.37 
8.92 
8.44 
5 191 Right superior frontal gyrus 10 22 63 -8 10.26 
6 122 Left inferior temporal gyrus 20 -32 0 -47 8.88 
7 1175 Right superior temporal 38 22 8 -45 8.88 
8 427 
Right superior temporal 
Right middle temporal gyrus 
22 
22 
64 
66 
-42 
-34 
10 
4 
8.12 
7.84 
9 246 Right frontal (precentral) gyrus 6 56 0 31 7.79 
10 28 Left superior temporal gyrus 22 -56 11 -2 7.33 
11 54 Left medial frontal gyrus 10 -3 66 6 7.27 
13 93 Right medial frontal gyrus 6 4 -19 54 7.13 
Coordinates are given in anatomical MNI space, and maxima shown are at least 8.0 mm apart. The 
center of mass of each ROI is shown in bold. Corrected for multiple comparisons (FWE, p < 0.05). 
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Table 2.4: Cluster of GMV recovery after 6 months of CR (N=24). Small volume 
correction (p<0.05, FWE). 
Cluster 
Number 
Volume 
(mm) 
Anatomical label 
Brodmann 
Area 
MNI Coordinate 
x        y      z 
t-value 
1 128 Right superior frontal gyrus 11 22 61 -10 10.26 
2 23 Right middle temporal gyrus 22 67 -37 13 7.20 
3 99 
Left posterior cerebellum (declive 
of vermis) 
NA 0 -72 -3 8.92 
 
 
2.4 Discussion 
 The key findings of the current study were lower GMV in the prefrontal cortex, 
parietal and temporal lobes of CAD patients compared to age-matched controls (Figure 
2.1 and Table 2.2) and increased GMV in the superior frontal gyrus, medial frontal gryus 
and superior temporal gryus after 6 months of cardiovascular rehabilitation (Figure 2.2 
and Table 2.3). This study is the first to show evidence of regional cortical brain atrophy 
associated with cardiovascular disease and also the ability of cardiovascular rehabilitation 
to reverse disease-related cortical atrophy. 
 
2.4.1 Cardiovascular disease effects 
 Our CAD group were patients diagnosed with either angina or myocardial 
infarction who were all receiving some form of treatment prior to the start of the study. 
Most patients were on a combination of drug therapy to lower lipid levels, maintain blood 
pressure, and to prevent reinfarction. The therapeutic impact of these treatments might 
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have contributed to the lack of any statistical differences in fasting blood glucose, resting 
supine blood pressure, cardiac output or heart rate between patients and controls. The 
CAD patients had lower lipid levels compared to controls, which can be attributed to the 
efficacy of statins in reducing serum levels of cholesterol
21
. However, mean hs-CRP, a 
marker of inflammation associated with increased risk of myocardial infarct or 
reinfarction, was higher for CAD patients than controls.  
 
2.4.2 CAD-related effects: Brain atrophy 
 The findings of decreased GMV in the frontal, temporal and parietal lobes of 
CAD patients are similar to the patterns of brain atrophy previously observed in patients 
with either hypertension or diabetes, in which marked declines in GMV were found in the 
prefrontal cortex, superior temporal and middle temporal lobes, thalamus, and 
hippocampus
3
. The regions common to all of these studies are associated with varying 
cognitive functions – executive function, attention, and memory, visuospatial and 
psychomotor speed – and are believed to be susceptible to vascular disease22. A study of 
400 men over the age of 40 found that cardiovascular disease was associated with poor 
performance in memory tests and a trend towards lower scores in mini-mental state 
examination
23
. Similarly, Okonkwo et al.
24
 reported an accelerated decline in the 
aforementioned cognitive domains in a large group of cardiovascular disease patients 
over a three year period that was not attributed to aging. In addition, numerous studies 
have linked markers of cardiovascular disease including impaired vascular 
hemodynamics (pulse wave variability, arterial stiffness, and ventricular function) to 
alterations in cognitive function
25,26
. In general, the observation of decreased GMV in the 
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frontal, temporal and parietal lobes indicates that CAD accelerates age-related neocortical 
degeneration, possibility leading to declining cognitive function.  
 Our findings of bilateral atrophy in the posterior cerebellum and in the inferior 
parietal lobule of the brain in the CAD group is novel given that these regions are usually 
preserved with age and atrophy has only been reported in a few dementia studies
27,28
. 
These studies linked poor performance on short-term memory and visuospatial tasks to 
GMV decline in either the cerebellum
27
 or the inferior parietal lobule
28
, highlighting the 
known importance of both regions in neurocognitive integration. Taken together, these 
observations suggest that in older adults, cardiovascular disease can precipitate changes 
in normally stable regions of the brain. 
 A significant difference in mean baseline MoCA scores between the CAD group 
and controls was found in the current study (Table 2.1). 24% of CAD patients had a score 
of 25 or less compared to 5% of controls. A MoCA score of less than 26 is typically 
considered to reflect mild cognitive impairment (MCI). However, there was no 
correlation between MoCA scores and regional brain atrophy. Considering the MoCA is 
a brief assessment tool of MCI
29
,  it may not be ideal for probing subtle cognitive decline 
in middle-aged adults since evidence of cognitive decline typically occurs after the age of 
60
30
. The apparent difference in MoCA scores between groups could possibly be a mere 
reflection of the difference in levels of education observed between groups. Education 
was associated with performance on MoCA (r=0.518, p<0.01), but not total or regional 
GMV. Similarly, Christensen et al
31
 found no link between level of education and global 
or regional brain atrophy in adults with no history of cognitive impairments. The use of 
tests more specific to the cognitive functions associated with the observed areas of brain 
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atrophy might reveal greater impairment. Nonetheless, the current data support the 
overall concern that CAD accelerates cortical atrophy with detrimental outcomes to 
cognitive ability. 
 The direct mechanism(s) that drive the greater brain atrophy associated with 
cardiovascular disease are unclear. One possible mechanism could involve cerebral 
hypoperfusion. Animal studies have shown that cerebral hypoperfusion from ischemic 
vessels can initiate pathophysiological changes in the brain structure and function of 
aging rats, resulting in decreased synaptic activity and impaired memory and visuospatial 
skills
32
. Human studies of diabetic and hypertensive patients have reported regional 
cerebral hypoperfusion in similar regions of the brain where atrophy has been 
reported
33,34
. Investigating cerebral blood flow or cerebrovascular dynamics with 
morphometric imaging would help elucidate potential neurovascular changes in CAD 
patients. 
 A common cause underlying both CAD and brain atrophy could be physical 
inactivity. Physical inactivity is an important modifiable risk factor for heart disease 
given that inactive individuals are twice as likely to suffer a coronary event in their 
lifetime compared to physically active individuals
35
. In this study, the CAD patients were 
40% less fit than controls and the less fit individuals were more likely to have lower 
global and regional GMV. In general, physical inactivity is associated with regional brain 
atrophy
36
 and cognitive decline
37
 in healthy older adults.  
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2.4.3 Effect of rehabilitation: neuroplasticity 
 The propensity for age and CAD to adversely affect the function and morphology 
of certain regions of the brain, namely the prefrontal, superior parietal, inferior temporal 
and middle temporal, suggests that these regions are highly malleable and perhaps more 
adaptive to change. Recovery of volume within these brain regions with exercise in both 
healthy aging subjects and dementia patients signifies that these regions are highly 
plastic
11,38,39
. These observations are in good agreement with our finding of increased 
GMV in the prefrontal, left middle temporal, left inferior temporal lobes in addition to the 
cerebellum, supplementary motor areas and right superior temporal gyrus of CAD 
patients after 6 months of CR. 
 The significance of aerobic fitness in improving cardiovascular and cerebral 
functions is well established and discussed in great detail in reviews by Erickson et al
39
 
and Lavie et al
40
. Briefly, with CAD, aerobic fitness is associated with a significant 
decrease in relative risk of mortality, improved ventricular function, and improved 
vascular dynamics
41
. In older adults and dementia patients, exercise training was 
associated with increases in regional brain volume, improved cognitive function, and 
increased neuronal activity
40
. Increases in regional GMV
13,42
 and cognitive function
43
 
have been reported after 6 months of moderate level of exercise training (40-70% of heart 
rate reserve). The prescribed 6 months of aerobic exercise, as part of the CR program, 
was sufficient to cause detectable changes in brain structures of CAD patients including 
changes in non-motor areas, despite the observed modest impact on aerobic fitness. 
 Findings of recovery of GMV in areas of the superior frontal lobe, superior 
temporal lobe and posterior cerebellum (Table 2.4) after a short period of exercise are 
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promising and indicate a unique positive outcome of CR. It could be postulated that 
recovery of brain volume in these regions could potentially be maintained over longer 
periods. Erickson et al.
43
 found retention of regional brain volume in older adults that 
performed low intensity exercise nine years after cessation of the activity.  
 
2.4.4 Study consideration 
 The impact of cardiac artery bypass grafting surgery (CABG) on neuroanatomy 
and cognitive function cannot be ignored. CABG is known to exert transient decrease in 
brain volume and cognitive function
44
. The interaction between cardiovascular disease 
and CABG on regional GMV was not explored given that only 8% of CAD patients in 
this study underwent CABG and this occurred a few months prior to the start of the 
study. 
 It is possible that the GMV changes observed post CR in CAD patients might not 
reflect the full potential neurorehabiltatory benefits of CR giving the moderate 
improvement in GMV post exercise training. Considerable changes could be achieved 
with either high-intensity aerobic exercises or activities such as basket ball, hockey or 
squash that incorporate motor skills along with cognitive and perceptual skills (areas 
which showed significant GMV decline with CAD). The lack of association between 
VO2max and GMV could be a result of the large number of patients who were unable to 
complete the graded exercise test for various reasons including the inability to reach 
maximal volitional exhaustion, which is common among CAD patients. Submaximal 
graded exercise tests or a 6 minute walk test could be used to evaluate cardiorespiratory 
capacity in CAD patients who cannot achieve maximal myocardial oxygen uptake. 
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However, submaximal VO2 tests often lack diagnostic accuracy, particularly tests that 
exclude heart rate measures with electrocardiography.  
 The innate methodological limitations of VBM are also drawbacks to the 
interpretation of our findings. The registration, segmentation and normalization steps in 
VBM can introduce bias and distortion errors particularly in the border of small 
subcortical GM structures where some proximal voxels can be misclassified
45,46
. This 
error is exaggerated in older brains prone to enlarged ventricles. We minimized these 
distortion errors with the use of a study-specific template and DARTEL registration 
method
19,46
. However, this inherent segmentation and registration bias can pose a 
limitation to the investigation of CAD-related regional brain volume changes in 
vulnerable subcortical regions such as the hippocampus where decline in volume have 
been previous reported in CAD
47
. For longitudinal studies, available intra-subject bias 
correction methods attempt to minimize the influence of baseline differences on images 
from subsequent time points. However, issues of registration asymmetry can be largely 
improved with symmetric diffeomorphoic approaches proposed for future versions of 
SPM, particularly for non-quantitative T1-imaging data
48
. 
 A potential limitation with this study was the use of two scanners in data 
acquisition. However, performing the analysis of the effects of CAD without the five 
patients imaged on the second scanner revealed no difference in the pattern of regional 
GMV differences reported in Table 2.2 and shown in Figure 2.1. Furthermore no 
significant effect was found by including scanner as a between-subject factor in the 
analysis of the rehabilitation data.  
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2.5 Conclusion 
 This study demonstrates that in stable CAD patients, cardiovascular disease is 
associated with brain atrophy in several brain regions, including those related to cognitive 
ability. This disease-related effect appears to be reversible as this study demonstrated that 
a modest aerobic program reversed some of the structural abnormalities.  
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3 Chapter 3 
 
Impaired Cerebrovascular Function in Coronary Artery Disease 
Patients, and Recovery Following Cardiac Rehabilitation. 
 
3.1 Introduction: 
 
 Cardiovascular disease increases the rate of age-related cortical atrophy
1
, the risk 
of dementia
2
, and the risk of stroke. These relationships likely are due to progression of 
vascular disease into the cerebral circulation. Cerebrovascular disease and alterations to 
the structure and function of the brain are increasingly associated with cardiovascular 
disease risk factors such as hypertension, atherosclerosis and diabetes
3
. This comorbidity 
of cardiovascular disease and neurological impairments in older adults is a growing area 
of concern, since aberrant brain changes related to vascular disease appear to affect 
regions involved in cognitive function
2
.  
 A number of studies have demonstrated that vascular disease processes accelerate 
brain decay and alter the natural age-related decline in cerebrovascular hemodynamics
4
. 
In asymptomatic older adults, decline in cardiac output is associated with global brain 
atrophy
5
, regional cerebral hypoperfusion
6
 and impairments in cognitive abilities
7
. 
Recently, we observed significant reductions in regional brain volume in the brains of 
coronary artery disease patients
1
 that are consistent with observations of cerebral atrophy, 
hypoperfusion, and white matter disease in brains of older adults with increased risk for 
vascular disease
3
. Although these observations suggest a possible link between 
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cardiovascular disease and neurological dysfunction, the interaction of age, vascular 
disease and cortical degeneration is complex and not well understood
4,6
. In addition, the 
effect of cardiovascular disease on cerebrovascular hemodynamics and function has not 
been fully characterized. Vascular diseases may accelerate cerebrovascular aging and in 
doing so, significantly alter normal cerebral blood flow distribution, inducing brain 
atrophy and cognitive decline
6
. However, no study to date has described regional 
cerebrovascular hemodynamics in individuals with ischemic vascular disease.   
 Building on our previous work, this study assessed cerebrovascular 
hemodynamics and relationships between hemodynamic changes and brain atrophy in the 
same cohort of coronary artery disease (CAD) patients and age matched controls. 
Furthermore the therapeutic effects of cardiac rehabilitation on cerebral blood flow 
(CBF) in CAD patients were assessed in a subsample. We explored regional changes in 
CBF and cerebrovascular reactivity to CO2 (CVR) in cognitive areas of the brains of 
CAD patients, since increased vascular resistance, common in CAD can diminish CVR
8
. 
Measurements of CBF and CVR were performed using arterial spin labelling (ASL).  
 
3.2 Materials and Methods:  
3.2.1 Participants 
 Participants were part of a larger prospective study examining the effects of 
cardiovascular disease on brain health. The CAD patients were recruited from the 
London Health Sciences Center for Cardiac Rehabilitation and Secondary Prevention 
program, and controls matched in age, were recruited from the local community. The 
present sample are subjects from a previous study
1
 and consists of 34 CAD patients (58 ± 
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7 years, 10 females) and 21 healthy controls (59 ± 8 years, 10 females) whom had MRI 
scans that included ASL acquisitions. Of the 34 patients, 17 (59 ± 6 years, 5 females) 
completed a 6-month CR program and participated in post-CR testing. CAD was defined 
by a history of one of the following: acute coronary syndrome (ST elevation or non-ST 
elevation myocardial infarct), angina, percutaneous coronary intervention, or coronary 
artery bypass surgery. Exclusion criteria included patients with congenital coronary 
abnormality, cardiomyopathy, severe congestive heart failure, second or third-degree 
atrioventricular block, more than two myocaridal infarcts, sick sinus syndrome, major 
arrythmias, uncontrolled hypertension or a history of diabetes for more than 5 years. 
Controls were excluded if they had clinical diagnosis of cardiovascular disease, 
hypertension and diabetes. All participants were free of neurological diseases, 
pharmaceutical or nutraceutical psychostimulants, nootropics and non-smokers. This 
study was approved by the Western University Health Sciences Research Ethics Board 
and written informed consent was obtained from all participants. 
 
3.2.2 Experimental design 
 Experimental data were collected over three testing sessions: 1) a laboratory 
session for assessment of clinical markers of vascular health, 2) graded exercise testing 
and 3) brain MRI. Subjects refrained from caffeine, alcohol and physical activity at least 
12 h before participating in each session. To capture global cognitive function, the 
Montreal Cognitive Assessment, (MoCA, http://www.mocatest.org) was administered 
during the laboratory testing. MoCA scores were corrected for level of education - 
defined by the total number of years of formal education, as described on 
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http://www.mocatest.org. The entire experimental protocol was repeated in the 17 CAD 
patients who performed 6 months of cardiac rehabilitation, which consisted of moderate-
intensity aerobic and strength fitness training. The aerobic training protocol was 
performed as previously described
1
 and as prescribed by the London Health Sciences 
Center Cardiac Rehabilitation and Secondary Prevention Program. 
 Cerebrovascular reactivity measurements were achieved by manipulations of 
arterial concentrations of CO2. Subjects breathed room air for 5 min, followed by 5 min 
inhalation of 6% CO2 mixed with 21% O2 and balanced nitrogen, while end-tidal partial 
pressure of CO2 (PETCO2) was recorded continuously (Invivo 3150m, Invivo Corp., 
Orlando, Florida). Air and mixed CO2 were delivered via a non-rebreathing facemask 
(Hans Rudolph Inc., Kansas City, Missouri) attached to a large non-diffusible gas 
reservoir bag. The breathing rate was paced at 15 breaths/minute guided by a metronome 
to minimize hyperventilation and maintain steady-state sampling of PETCO2. The 
hypercapnia challenge was performed first in the laboratory in supine position to 
acclimatize participants prior to repeating the challenge during brain imaging. 
Participants unable to perform hypercapnia testing or who had a change in PETCO2 
(ΔPETCO2) of 5mmHg or less in the laboratory examinations did not perform the 
challenge during the MRI session. Instead only resting CBF images were acquired.  
  
3.2.3 Clinical measurements 
 To assess levels of plasma lipids, cholesterol, blood glucose, glycated hemoglobin 
(HbA1c) and high-sensitivity C-reactive protein (hs-CRP), blood samples were collected 
under fasting conditions and analyzed using standard assays and glucometer. Three-lead 
 114 
 
electrocardiogram and finger blood pressure monitoring (Finometer; Finapres Medical 
Systems, Amsterdam, the Netherlands; calibrated to sphymomanometric values) were 
performed concurrently over a 20 min period. Mean values for heart rate, systolic blood 
pressure, diastolic blood pressure and mean arterial pressure were reported from 
measures averaged over 5 min. Vascular hemodynamic measurements were performed on 
the right common carotid artery using Doppler ultrasound imaging (Vivid 7, GE 
Healthcare). Carotid vessel diameter, wall thickness and intima media thickness were 
measured from 2-dimensional (2D) B-mode images acquired in the long-axis plane by a 
single observer blinded to subject identity or group assignment. Arterial compliance and 
distensibility were calculated from measures of vessel diameter and pressure at end 
systole and end diastole
9
. A 2D transthoracic Doppler echocardiogram (Vingmed System 
FiVe, GE Healthcare, Chalfont St Giles, UK) was performed to assess left ventricular 
ejection fraction (EF) - a clinical index of cardiac function. Graded exercise testing was 
performed to volitional exhaustion to measure cardiorespiratory fitness level or capacity 
(maximal oxygen consumption, VO2 max), in accordance with the American College of 
Sports Medicine guidelines for exercise testing.  
 
3.2.4 MRI data acquisition 
 All MRI brain imaging was performed on a Siemens 3T Verio system (Siemens 
Medical Systems, Erlangen, Germany) using a 32-channel head coil. The head was 
immobilized with foam padding to minimize motion artefacts. Sagittal T1-weighted 
images were acquired using a three-dimensional magnetization-prepared rapid gradient-
echo (MPRAGE) sequence (repetition time (TR), echo time (TE) and inversion time (TI) 
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= 2000, 2.98 and 900 ms, flip angle = 9°, field of view (FOV) = 256 x 256 mm
2
, 176 
slices, isotropic voxel size = 1.0 mm
3
, acceleration factor = 3) to measure cortical 
thickness. ASL images were acquired during hypercapnia testing using a transverse 2D 
gradient-echo echo planar imaging (EPI) sequence (TR/TE = 3500/12 ms, FOV = 240 x 
240 mm
2
, 12 contiguous slices, 6 mm thickness, voxel size = 3.8 x 3.8 x 6 mm
3
, 
bandwidth = 2298 Hz/Px, acceleration factor of 2) and a pseudo-continuous label 
method
10
 applied 9 cm below the center of the imaging volume for a duration of 1.5 s. 
One-hundred and ten label and control pairs were acquired after a 1.0 s post-label delay. 
A non-selective inversion pulse was applied for background suppression during the post-
label delay. To improve signal-to-noise (SNR) and sensitivity of ASL for CVR 
measurements, ASL imaging and hypercapnia testing were repeated after a 3 min 
recovery period. Additional imaging for CBF quantification included; a) proton density 
calibration scan (M0) acquired with the ASL sequence using a TR of 7 s and no label or 
background suppression pulses, and b) axial single-shot inversion-recovery prepared 
balanced steady-state free precession imaging (IR-TrueFISP) acquired with 10 variable 
TI (175 to 8000 ms) on a single slice at the mid-sagittial section of the brain (TE =  1.21 
ms, 1.7 x 1.7 x 4 mm, acceleration factor of 2). These images were used to measure the 
longitudinal relaxation time of blood (T1b) in the sagittal sinus
11
.  
 
3.2.5 Perfusion-weighted analysis 
 Preprocessing and analysis of perfusion data were performed with SPM8 
(http://www.fil.ion.ucl.ac.uk) and scripts written in MATLAB (2012a, The MathWorks, 
Natick, MA). All ASL and M0 scans were aligned to the first time point of the first scan 
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to correct for head motion within sessions (two trials) and between sessions (pre and 
post-CR). Intra-subject alignment was performed on MPRAGE images using the VBM8 
longitudinal toolbox (http://dbm.neuro.uni-jena.de/vbm) in SPM8 to minimize intra-
subject registration errors. Using a rigid-body transformation, respective MPRAGE 
image volumes were aligned to corresponding ASL scans (i.e. baseline MPRAGE to 
baseline ASL and post-CR MPRAGE to post-CR ASL),  and segmented into gray matter 
(GM), white matter (WM) and cerebrospinal fluid (CSF) probability images using the 
new segment tool in SPM8. The GM segments were transformed into binary masks 
thresholded for voxels with 80% or more GM content and applied to the ASL time series. 
This was done to minimize ASL signal contributions from WM and CSF. Forty label and 
control images were extracted from each 5 min block at steady-state, surround subtracted 
and time-averaged over the two trials to generate perfusion-weighted (ΔM) images. CBF 
was calculated using a standard single-compartment flow model
10
.  
𝐶𝐵𝐹(𝑚𝑙/100𝑔/𝑚𝑖𝑛) =
6000 ∙ 𝜆 ∙ 𝛥𝑀 ∙ 𝑒
 
𝜔
𝑇1𝑏
 
2𝛼 ∙ 𝑀0 ∙ 𝑇1𝑏 ∙  1 − 𝑒-
 −
 𝜏+𝜔 
𝑇1𝑏
 
 
 
where λ = blood/tissue water partition coefficient, 0.9 g/mL;  α = labelling efficiency 
assumed to be 85%
11
 multiplied by 94% for background suppression; ω = post-labelling 
delay of 1.0 s incremental per slice; τ = label duration of 1.5 s and T1b  = individual blood 
T1 value. The final individual normocapnia and hypercapnia CBF images were smoothed 
using a Gaussian filter with a FWHM of 6 mm and transformed to standard stereotactic 
space (MNI) using transformation parameters from segmentation of MPRAGE images. 
CVR was calculated pixel-by-pixel as the increase in CBF per mm Hg increase in 
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PETCO2. All further reference to CBF refers to CBF measured at room air, unless 
otherwise stated.  
 To assess the sensitivity of the ASL sequence used in this study, the temporal 
signal-to-noise ratio (tSNR) of the perfusion-weighted time series was calculated for each 
subject. Temporal SNR was defined as the mean GM pixel signal relative to the mean 
GM pixel standard deviation. The reproducibility of repeated ASL measurements was 
determined from a subset of patients and controls (N=19) for baseline CBF and CVR 
using within-sessions coefficient of variation and intraclass correlation coefficient (ICC). 
ICC was calculated using SPSS and two-way random model with measures of 
consistency, where a value close to 1 represents a high reliability. For completeness, the 
test-retest reliability at baseline was also compared voxel-by-voxel using repeated 
measures analysis of variance. This was done to ensure that averaging the perfusion-
weighted signal from the 2 trials did not bias group comparisons.    
 
3.2.6 Assessment of structure-independent CBF effects 
 Our goal was to relate cerebral hemodynamic changes to underlying structural 
changes in brain volume
1
 on a voxel-by-voxel basis to see if hemodynamic abnormalities 
(i.e. hypoperfusion or reduced CVR) and brain atrophy were mutually dependent. Thus, 
to delineate perfusion changes from underlying structural changes, a multimodal voxel-
by-voxel multivariate analysis was performed as a two-step process as outlined in figure 
3.1. First, an exploratory analysis was performed on the CBF images across all voxels 
with greater than or equal to 80% gray matter, to identify regions with significantly 
different gray matter CBF between CAD patients and controls. This was achieved using 
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two-tailed Student's t-test performed within SPM8. Next, these clusters were passed to 
the biological parametric mapping (BPM)
12
 tool, where a voxel-by-voxel analysis of 
covariance (ANCOVA) was performed on CBF images with differences in regional gray 
matter volume (GMV) removed. The results reflected differences in regional gray matter 
perfusion independent of gray matter volume changes.  
 For the BPM analysis, individual GMV images were generated from MPRAGE 
volumes using voxel-based morphometry (VBM, http://dbm.neuro.uni-jena.de/vbm/) in 
SPM8 as described in a prior study
1
. The GM segments were spatially normalized to a 
template averaged from all subjects, corrected for differences in brain size and smoothed 
with an 8-mm Gaussian filter. To describe changes in GMV within the clusters of 
interest, a voxel-by-voxel between-group comparison was performed on the GMV 
images and restricted to the clusters of interest using SPM8. An absolute threshold mask 
set at 0.1 was used to remove non-GM voxels. For all statistical analysis, type I errors 
from multiple comparison was minimized using False Discovery Rate (FDR) at p <0.05 
and cluster size greater than 10 voxels.  
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Figure 3.1: Illustration of the pipeline for multimodal voxel-wise ANCOVA 
performed to determine the singular effect of CAD on regional CBF. 
 
Step 1 involved SPM voxel-wise between-group comparisons of CBF images across the brain. 
Significant clusters from this step were converted to binary masks and used in Step 2 to improve 
voxel-wise multimodal analysis and limit type II errors. In step 2, between-group differences in CBF 
were examined voxel-wise using BPM with GMV images from VBM analysis serving as covariates. 
Corrections for multiple comparisons using FDR (p<0.05) was performed at each step. Clusters that 
remained signified regions where CBF changes drive the observed differences as in figure 3.2B and as 
listed in table 3.2. Illustration was overlaid on glass brains from SPM8 
(http://www.fil.ion.ucl.ac.uk/spm/). 
 
3.2.7 Statistical analysis 
 Statistical analyses were conducted with SPSS 20.0 statistical software (IBM 
Corp. Armonk, NY, and USA). Baseline clincal assesments and regonal CVR measures 
from CAD patients were compared to data from the control group using two-tailed 
Student's t-test since age and gender were matched. Since, lower CVR was expected in 
the CAD
8
 group compared to controls, a one-tailed t-test was performed on regional 
mean CVR values extracted from each of the clusters from results of ANCOVA BPM 
analysis. Voxel-by-voxel comparisons were not performed on CVR images because of 
power constraints.  
 To test for effects of aerobic fitness, a paired t-test was performed on clinical data 
and regional CBF measures acquired on a subgroup of CAD patients before and 6 months 
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after cardiac rehabilitation. Regional CBF values were extracted from each of the clusters 
from the baseline ANCOVA BPM analysis. To demonstrate recovery of CBF with 
cardiac rehabilitation within regions, percent relative differences were computed for 
CAD patients at baseline and after CR. Baseline differences were relative to each 
regional mean CBF across all control subjects, while post-CR differences were relative to 
pre-CR regional CBF values. For completeness, relative differences were also computed 
for regional GMV. CVR analysis were not performed post CR due to a lack of statistical 
power.  
  
3.3 Results 
3.3.1 Study demographics 
 Perfusion data from one control subject and one CAD patient at baseline were 
excluded because of motion artefacts. Thirteen control subjects and 22 CAD patients 
participated in CVR measurements. The CVR data of one patient were excluded due to 
accelerated breathing (>25 breathes per minute) during hypercapnia, which can confound 
CVR results. The CAD group consisted of patients with clinical diagnosis at referral of 
angina (11.7%), myocardial infract (17.6%) and coronary artery disease (67.6%). All 
patients were on a combination of drug therapy to lower lipid levels (statins = 83.3%), 
maintain blood pressure (beta-blockers = 72.2%; ACE-inhibitors/angiotensin II receptor 
blockers = 50%) and prevent reinfarction (anti-platelets/aspirin = 77.8%). Forty-one 
percent had percutaneous coronary intervention and 8.8% received coronary artery 
bypass grafting prior to participation in the study. 
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3.3.2 Baseline clinical measures 
 Results of clinical assessments compared between groups at baseline including 
global means of gray matter CBF and CVR are presented in Table 3.1. There were no 
significant differences between patients and controls in terms blood pressure, left 
ventricular function, resting heart rate and blood glucose. CAD patients had lower total 
cholesterol (F = 15.34 (1, 53), p<0.0001) likely reflecting the therapeutic effect of the 
combined drug therapy received by patients. However, CAD patients had lower MoCA 
scores (F = 4.63 (1, 51), p<0.01) after adjustment for level of education, lower VO2max 
(F = 15.02 (1, 37), p<0.0001), elevated BMI (F = 18.46 (1, 53), p<0.0001) and higher 
carotid artery intima media thickness (F = 8.05 (1, 43), p<0.001). There was also a trend 
of reduced carotid compliance in the carotid (p = 0.24) and elevated hs-CRP (p = 0.10), a 
marker of inflammation and measure of myocardial infarction risk.  
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Table 3.1: Study demographics 
Variables 
Controls Patients 
Body mass Index (kg/m
2
) 24.54 ± 3.11 29.84 ± 4.73* 
Glucose (mmol/L) 4.72 ± 0.89 5.21 ± 1.38 
Total cholesterol (mmol/L) 4.15 ± 0.96 3.09 ± 0.79* 
hs-CRP (mg/L) 0.97 ± 0.91 2.10 ± 3.10 
Systolic blood pressure (mm Hg) 120.28 ± 15.97 126.70 ± 21.20 
Diastolic blood pressure (mm Hg) 68.18 ± 7.8 71.5 ± 12.41 
Heart rate (beats per min) 58.34 ± 9.54 59.11 ± 6.85 
Left ventricular ejection fraction (%) 67.41 ± 9.82 64.35 ± 7.24 
Intima media thickness, carotid (mm) 0.53 ± 0.12 0.64 ± 0.12* 
Compliance, carotid (mm/mm Hg) 0.0088 ± 0.003 0.0077 ± 0.003 
MoCA 28.32 ± 1.67 26.82 ± 2.1* 
VO2max (mL/kg/min) 37.27 ± 9.94 26.9 ± 7.24* 
Resting PETCO2 (mm Hg) 43 ± 4 40 ± 6 
ΔPETCO2 (mm Hg) 11 ± 3 13 ± 4 
Global mean CBF (mL/100g/min) 50.83 ± 11.68 46.49 ± 13.88 
Global mean CVR (mL/100g/min/mm Hg) 2.57 ± 0.62 2.26 ± 0.63 
Means and standard deviations of clinical assessments compared between CAD patients 
and controls. Statistical differences between groups at p<0.05 are indicated by *.  
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3.3.3 Baseline brain imaging: Cardiac disease effects 
  The mean T1b across all subjects was 1562.6 ± 69.8ms. There was no difference 
between T1b for patients and controls. Mean GM tSNR for the ASL-EPI sequence was 
4.0 ± 1.4. Test-retest reliability of the CBF and CVR measurements performed voxel-
wise, showed no differences between trials (p <0.001, uncorrected). Because of the 
reproducibility of GM CBF and CVR, CV = 6.4% for CBF and 14.9% for CVR with 
corresponding ICC (2, 1) values of 0.93 and 0.82 for CBF and CVR respectively, ΔM 
signals were averaged over the 2 trials. No differences were found in global mean CBF or 
CVR between CAD patients and controls. Results from the multimodal voxel-wise 
multivariate analysis are listed in table 3.2 and are represented graphically on a single 
slice through the brain in figure 3.2. The results were as follows: 
1) Eleven clusters were identified as having significantly lower CBF in the CAD 
patients from the SPM exploratory step. The corresponding anatomical labels are 
listed in table 3.2.  
2) All eleven clusters remained significant after controlling for differences in GMV 
between the two groups. However, the magnitude of the effect of disease on CBF 
observed after atrophy correction was muted in nearly all regions, except in the 
right anterior cingulate cortex and bilateral middle temporal gyri (table 3.2).  
3) The cluster size of nearly all regions was also preserved after BPM ANCOVA 
analysis except in the left precentral gyrus where the cluster size was reduced by 
2 voxels.  
4) Within the 11 regions, a significant decrease in GMV was observed in the CAD 
group in the right and left superior frontal and in the left precentral gyri. These 3 
 124 
 
regions also had the greatest reductions in CBF changes following BPM analysis, 
as indicated by reduced t-value (table 3.2).  
In general, the brains of CAD patients had significant reductions in regional GM CBF 
independent of GMV in the bilateral prefrontal, insula, middle temporal, superior 
temporal, postcentral gyri, and in the right anterior cingulate cortex. Concomitant 
decrease in GMV and atrophy-independent CBF were observed in the right and left 
superior frontal, and in the left precentral gyri.  
 Between-group comparisons in regional CVR are shown in figure 3.3. Group 
means from each cluster and the standard error of the means are displayed. Significant 
decreases in CVR were observed in the CAD patients in the right anterior cingulate, 
bilateral superior frontal gyri, right insular, right precentral gyrus, left superior 
temporal/insula and left postcentral gyrus (all, p<0.05). 
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Figure 3.2: Regions of interest analysis from voxelwise-comparisons. 
 
Results of the region of interest analysis from voxel-wise comparisons between patients and controls; 
in gray matter CBF from SPM and from BPM analysis, and comparisons in gray matter volume 
derived from VBM. Clusters of significant difference between groups are depicted in yellow (p<0.05, 
FDR, cluster threshold = 10 contiguous voxels) and overlaid on the axial, coronal and sagittal slices of 
a single subject. The corresponding anatomical coordinates [x, y, z] are included.  
 
 
Figure 3.3: Regions of differences in regional CVR compared between CAD patients 
and controls at baseline. 
 
Statistical differences between groups at p<0.05 are signified by * and error bars indicate standard 
errors of the mean. R = right; L = left; SFG = superior frontal gyrus; ST = superior temporal gyrus; 
Ins = insula; PostC = postcentral gyrus; MT = middle temporal gyrus; PreC = precentral gyrus; AC = 
anterior cingulate. 
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Table 3.2: Results of multimodal voxel-by-voxel multivariate analysis. 
 
Brain region  
(Brodmann Area) 
Talariach  
coordinate  
(X Y Z) 
# of 
voxels 
SPM    t 
SPM 
p  
BPM t BPM  p  
Regional gray matter CBF,  controls > patients 
1 L Superior temporal (41) -34 -30 14 119 5.64 0.01 5.20 <0.001 
 L Insula (13) -38 -23 3  5.03 0.04 4.97 <0.001 
2 L Superior frontal (10) -22 50 -1 63 5.11 0.01 4.57 <0.001 
3 R Anterior cingulate (24) 6 31 0 18 4.91 0.01 4.98 <0.001 
4 L Postcentral gyrus (3) -38 -20 42 36 4.79 0.01 3.55 <0.001 
5 R Postcentral gyrus (6) 53 -6 28 35 4.71 0.01 3.95 <0.001 
6 R Middle temporal (39) 46 -62 20 57 4.47 0.02 4.50 <0.001 
 R Superior temporal (39) 55 -57 23  4.23 0.03 4.15 <0.001 
7 R Insula (13) 36 -28 18 33 4.25 0.03 3.36 <0.001 
8 R Superior frontal (10) 26 49 -1 21 4.21 0.03 3.23 0.002 
9 
†
L Precentral gyrus (4) -55 -8 28 14 4.18 0.03 2.49 0.008 
10 R Precentral gyrus (6) 46 -10 28 10 4.11 0.03 3.01 0.003 
11 L Middle temporal (39) -46 -69 16 18 3.61 0.04 3.69 <0.001 
VBM: Regional GMV,  controls > patients 
1 L Superior frontal (10) -22 56 2 40 3.90 0.009   
2 R Superior frontal (10) 26 54 2 21 3.88 0.009   
3 L Precentral gyrus (4) -56 -10 34 14 3.00 0.014   
Results of regional voxel-by-voxel comparisons in regional CBF and in regional GMV between CAD 
patients at baseline. Effect magnitude is represented by t-static from SPM analysis and from BPM 
analysis, where changes in gray matter volume were accounted for. Results were corrected for 
multiple comparisons (FDR, p<0.05). Coordinates of local maxima of clusters of significant difference 
are listed and given in anatomical Talariach space. R = right; L = left; 
†
for the left precentral gyrus, the 
total number of voxels from BPM analysis was reduced to 12.   
 
 
3.3.4 Cardiac rehabilitation effects 
 There were no differences within the CAD patient group in pre- and post-CR 
clinical tests. Mean VO2 max at baseline and post-CR were 28.04 ± 10.47 mL/kg/min and 
29.37 ± 8.74 mL/kg/min respectively. No difference in global mean gray matter perfusion 
was observed before (46.4 ± 11.4 mL/100g/min) and after (50.0 ± 18.5 mL/100g/min) 
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exercise training. Regional mean CBF at baseline and post-CR are shown in figure 3.4. A 
significant increase in CBF (~30%) was seen post exercise in the right anterior cingulate 
(p = 0.02), a region where a comparable decline in CBF compared to controls (~33%) 
was observed at baseline, and a region where no change in GMV was observed after 
exercise. An increase in GMV with exercise was found in the bilateral pre- and post-
central gyri and in the right superior frontal gyrus, while a sustained decrease in GMV 
over time was seen in the left superior temporal and right insula regions. 
Figure 3.4: Regions of differences in regional CBF compared in CAD patients 
before and after CR. 
 
Statistical differences at p<0.05 are signified by * and error bars indicate standard errors 
of the mean. See figure 3.3 for full name of regions.  
 
3.4 Discussion 
 There is a growing interest in the potential role of vascular disease in advancing 
the age-related decline in cerebrovascular health and cognitive function. In a recent study, 
we described marked brain atrophy spanning the frontal, temporal and parietal lobes of 
CAD patients, and subsequent increase in brain volume with exercise
1
. Here, in the same 
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cohort of CAD patients, accelerated cerebrovascular decline was observed in cognitive 
areas of the brain. Interestingly, these changes were greater than the corresponding 
declines in brain volume, suggesting that cerebral hypoperfusion associated with 
cardiovascular disease could mediate neuronal volume loss. In addition, recovery of 
perfusion in the right anterior cingulate was demonstrated after six months of exercise 
training. These findings indicate that cardiovascular disease is associated with regional 
cerebral hypoperfusion and diminished CVR, which indicate cerebrovascular dysfunction 
and that these changes may be reversible with exercise.  
 Vascular aging is associated with increased plaque burden, impaired vascular 
remodelling, arterial stiffness and endothelial dysfunction
13
, inducing perfusion deficits 
that in turn decrease the amount of oxygen available for optimal tissue function
13
. In the 
brain, for example by the age of 60, normal aging can reduce regional CBF by up to 
15%
14
, offsetting the normal coupling of CBF to glucose metabolism
14,15
. This age-
related compromise in CBF is exacerbated by the presence of vascular disease, as 
demonstrated by our findings and supported by previous observations
6
. Compared to age-
matched controls, we found decreased CBF in the brains of CAD patients in regions 
known to be affected by various forms of vascular disease (for review see de la Torre
6
 
and Friedman et al
3
). For instance, hypertension is associated with accelerated decline in 
regional perfusion in the orbitofrontal, anterior cingulate and insular cortices
16
. In older 
adults with various forms of cardiovascular disease, reductions in frontal and temporal 
lobe CBF are associated with reduced regional cortical thickness and impairments in 
memory, attention and executive functions
17
. The combined effect of vascular ageing and 
high blood cholesterol leads to slow progression of atherosclerosis, where the narrowing 
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of coronary, systemic or cerebral vessels can impede blood flow to the corresponding 
tissue. With CAD, it is possible that subtle changes in blood supply to the brain could 
pose an additional risk to the aging brain
5
, particularly in individuals with suspected 
central arterial stenosis. We found significantly higher carotid intima media thickness, a 
marker of generalized atherosclerosis
18
, in CAD patients compared to controls as well as 
decreased carotid artery compliance. Increased carotid intima media thickness in older 
adults, even in the absence of clinical vascular disease, is associated with regional 
changes in CBF
19
, increased risk for AD
18
 and accelerated decline in performance on 
tests for memory, language (semantic association fluency) and executive function, over 
time
20
. Arterial stiffness, even at the level of the aorta
7
, and other vascular remodelling 
responses to vascular disease impair CVR
21
, ultimately affecting higher-order cognitive 
processes.  
 CVR was significantly reduced in CAD patients in multiple regions including the 
anterior cingulate, superior frontal and postcentral gyrus. Typically, CBF reductions are 
likely either a result of reduced supply to tissue, signifying vascular dysfunction, or a 
result of reduced metabolic demand, signifying a decline in neuronal activity. The 
observed reduction in CVR in areas of reduced CBF in the CAD patients supports the 
former since it indicates that the brain's vascular response to a vasoactive stimulus was 
impaired, which suggests that the CBF response to increased functional activation may 
also be impaired
22
.  
 The decline in cognitive abilities in domains of executive function, attention, 
language, memory and visuospatial skills seen in vascular disease patients, independent 
of normal aging effects
23
, is consistent with the regional pattern of decreased resting CBF 
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and CVR observed in these CAD patients. Interestingly, these patients also had lower 
MoCA scores compared to controls, after adjusting for level of education. Impaired CVR 
is associated with a decline in global cognitive function in dementia patients
24
 and could 
reveal cognitive dysfunction sooner and with greater sensitivity than resting CBF. Lu et 
al
25
 demonstrated that CVR in the prefrontal cortex showed an accelerated decline with 
age compared to CBF. These observations underscore the significance of CVR as a 
marker of cerebrovascular health and potentially of cognitive function in cardiovascular 
disease patients.  
 One of the main findings of the current study was the observation of differences 
in the spatial patterns of hypoperfusion and brain atrophy in the CAD patients. Of the 11 
clusters identified as having lower basal CBF, only 3 clusters- all within the prefrontal 
cortex- showed a concurrent decrease in GMV following BPM analysis. A spatial 
mismatch between regional hypoperfusion and atrophy has also been observed in normal 
aging
26
. These observations suggest that certain areas of the brain respond differently to 
hemodynamic and structural changes associated with aging and vascular disease. It is 
also possible that the CBF changes observed in CAD patients could precede structural 
changes. It is important to consider that the poor spatial resolution of ASL compared to 
structural imaging could lead to partial volume errors. To minimize this, differences in 
CBF between patients and controls were only conducted in voxels that were classified as 
being comprised of at least 80% gray matter, followed by BPM analysis to control for 
changes in GMV. An alternative approach would be to use linear regression methods 
such as outlined by Asllani et al
27
 to extract a GM CBF image. However, this approach 
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can introduce substantial spatial blurring, which when applied to regions as small as those 
identified in the current study, could eliminate the observed effects.     
 Another notable finding of the current study was the recovery of CBF in the right 
anterior cingulate after mild-to-moderate aerobic fitness training. This finding agrees 
with a previous study that reported higher CBF in the anterior cingulate cortex in 
aerobically-trained older adults compared to sedentary controls
28
. A positive correlation 
between CBF in the anterior cingulate and VO2max has also been reported in CAD 
patients
29
. Similar to Chapman et al
28
, we observed no increase in global CBF after 
exercise training; however, the effects of exercise on global CBF are conflicting
30
. 
Conversely, Colcombe et al associated the level of aerobic fitness with decreased activity 
in the anterior cingulate and increased activity in the middle frontal, superior frontal and 
parietal regions in older adults performing conflicting response tasks
31
. Though they 
attributed their observation to improved adaptations in the attentional network following 
exercise training
31
, it could also signify the effects of exercise in enhancing both 
cognitive and cardiovascular control
32
. Decreased activity in the anterior cingulate 
(subgenual) and medial prefrontal cortex along with increased activity in the insular 
cortex, are strongly associated with cardiovascular adjustments to acute stressors during 
physical, cognitive and emotional demands
32
. Although we did not find significant 
changes in CBF in the insular or prefrontal regions after exercise training, we previously 
reported increased brain volume in the medial prefrontal region in addition to other 
cognitive areas
1
. Increased volume in the prefrontal, anterior cingulate and medial 
temporal lobes are consistently associated with improved higher cardiorespiratory fitness 
level
33
. It is possible that one of the mechanisms by which aerobic fitness training 
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improves cardiovascular function is the augmentation of cortical control of 
cardiovascular homeostasis. We were unable to investigate regional CVR response to 
exercise training given the relatively small sample, a global increase in CVR has been 
reported in older adults following 12 weeks of mild-to-moderate aerobic exercise
34
 and in 
stroke patients
35
 after completing a 6-month exercise program. In general, our findings of 
recovery of regional CBF following cardiac rehabilitation continue to support the role of 
aerobic fitness in preservation of brain health following injury. 
 
3.4.1 Study considerations 
 The findings presented in the current study although largely attributed to coronary 
artery disease, could also be associated with lifestyle factors
3
. Compared to controls, 
CAD patients had significantly lower fitness levels and were generally overweight. The 
effect of these lifestyle factors on cerebral perfusion and brain structure in the presence of 
vascular disease are yet to be determined. A large majority of the CAD patients were on 
antihypertensive and hypolipidemic drug. These agents are known to affect 
cerebrovascular hemodynamics and could mask vascular disease effects or attenuate 
exercise effects. Stains for instance are hypolipidemic agents associated with increased 
CBF and vascular reactivity
36
, while antihypertensive drugs such as beta-blockers can 
limit submaximal exercise capacity
37
. Furthermore, we did not explore potential ongoing 
cerebrovascular disease in the study population, specifically, white matter lesions, which 
could further contribute to cerebral hypoperfusion and atrophy. Our analysis, however, 
focused on vascular disease effects within gray matter. Areas associated with white 
matter hyperintensities are typically deep within white matter regions.  
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 Other study considerations include the inherent limitations with the ASL imaging 
and the hypercapnic challenge. First, the 2D EPI readout used in this study for ASL 
imaging, limited data acquisition to slices superior to the anterior commissure - posterior 
commissure line. As such, regions near tissue-air/bone interfaces prone to increased 
susceptibility artefacts were excluded. Cerebral hypoperfusion may well exist in the 
inferior regions of the frontal and parietal lobes, since brain atrophy has been observed in 
these regions in the same cohort of CAD patients
1
. Second, our choice of post-labelling 
delay was relatively short. It was selected to mediate the effects of short arterial transit 
time at high flow velocities during hypercapnia and increase SNR. This resulted in a 
tSNR comparable to newer ASL methods using three-dimensional gradient-spin echo
38
 
readouts, where whole brain coverage can be achieved at longer post-label delay and 
minimal susceptibility issues. A short post-labelling delay could result in an 
underestimation of CBF in patients with longer transit times, however no watershed 
artifacts, which are typical of transit time errors, were observed in the CBF images. 
Lastly, the CVR results were limited by a small sample size due to poor compliance with 
the hypercapnic manipulations, compounded by inter-subject variability in ventilation 
response during CO2 inhalation. Reproducible changes in PETCO2 were achieved by 
controlling the respiration rate using a metronome. However, commercial devices 
designed to control PETCO2 breath by breath, such as the RespirAct (Thornhill Research, 
Toronto, Canada) would improve the sensitivity of CVR measurements.  
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3.4.2 Conclusion 
  This study represents a concerted attempt within a single cohort to 
investigate the association between cardiovascular disease and cerebral hemodynamics, 
as well as investigating the potential benefits of physical activity. The findings 
demonstrated a region-specific vulnerability to cardiovascular disease that appeared to 
accelerate the normal changes in CBF associated with aging. It is possible that reductions 
in regional CBF and CVR, related to vascular disease could drive cortical decline. 
However, the fundamental mechanisms underlining the association between vascular 
disease and cortical decline remain unclear and require further investigation. The ability 
of an aerobic fitness program designed for CAD patients to improve cerebral perfusion 
was demonstrated in a relatively small sample. This work sets the stage for future 
investigations in larger cohorts of vascular disease patients to understand how 
cardiopulmonary fitness training impacts cerebrovascular hemodynamics.  
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4 Chapter 4 
 
Feasibility of Simultaneous Whole-brain Imaging of Cerebral Perfusion 
and Glucose Metabolism on a Whole-body Integrated PET-MRI 
Scanner. 
 
The chapter is adapted from the paper entitled "Feasibility of simultaneous whole-brain 
imaging on an integrated PET-MRI system using an enhanced 2-point Dixon attenuation 
correction method", published in Frontiers in Neuroscience, 2015; (8) :434, by Udunna C 
Anazodo, Jonathan D Thiessen, Tracy Ssali, Jonathan Mandel, Matthias Günther, John 
Butler, William Pavlosky, Frank S Prato, R Terry Thompson, and Keith S St. Lawrence. 
It is reproduced here under a Creative Commons Attribution CC-BY license. 
  
4.1 Introduction 
 Multimodal imaging approaches that simultaneously pull together structural, 
functional and molecular information have the potential to improve the characterization 
of normal and/or abnormal neurophysiology. The development of positron emission 
tomography (PET) and magnetic resonance imaging (MRI) hybrid systems provide the 
combined advantages of high molecular sensitivity of PET and high spatial resolution of 
MRI, among other benefits. The clinical potential of this hybrid approach extends beyond 
image fusion considering the ability of MRI to collect data associated with not only 
anatomy but also function, diffusion and metabolite concentrations
1
, thereby maximizing 
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diagnostic accuracy
2
 as image registration errors and total image acquisition times are 
minimized, and physiological and metabolic states are identical. 
 However, accurate correction of PET signal attenuation in PET-MRI hybrid 
systems using information derived from MRI is challenging. Inherent limitation(s) of 
various proposed attenuation correction methods can lead to PET quantification errors of 
up to 20%
3–6
, which limits adoption of PET-MRI in neuroimaging. Commercial PET-
MRI hybrid systems rely on MRI-derived attenuation correction (MRAC) using a 2-point 
Dixon method
7
 based on segmentation of MR signals from water and fat into air, lung, fat 
and soft tissue
8
 but ignores bone, rendering this method less ideal for brain imaging. 
Various methods have been explored to produce optimal MRAC maps for neuroimaging 
that are as accurate as clinically accepted AC maps produced by computed tomography 
(CT). Ultra-short echo (UTE) MRI
9
 where bone is imaged and incorporated into AC 
maps, can suffer from low spatial resolution and inaccurate signal segmentation
4
. 
Methods that employ CT templates/atlases mapped to individual MRI
10,11
 or to guide 
MRI segmentation
12–14
, require complex algorithms that have limited reproducibility and 
at best still retain some level of inter-modality misregistration
15
, especially where large 
signal intensity differences exist between MRI and CT (e.g. cortical bone).  
  In this study we explored the feasibility of hybrid PET-MRI systems in 
simultaneous measurements of brain function with PET and MRI using an enhanced 
Dixon-based MRAC for PET signal attenuation correction in an integrated PET-MRI 
system. Simultaneous functional imaging was achieved by combining 3-dimensional 
(3D) pseudo-continuous arterial spin labelling (pCASL) with 
18
F-fluoro-deoxyglucose 
(FDG) PET since FDG is considered a suitable surrogate marker of brain function
16
 and 
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pCASL is a reliable MR perfusion method for assessment of brain function under resting 
and task-induced conditions in normal and disease states
17
. The goal was to investigate if 
regional correlations in relative cerebral blood flow (rCBF) to relative cerebral rate of 
glucose consumption (rCMRglc) measured with a hybrid PET-MRI scanner were 
comparable to previous studies using either PET alone
18
 or separate PET and MRI 
systems
19
. If successful, the obvious advantage is that future studies in neuropsychiatry or 
neurodegeneration, for instance, could correlate perfusion MRI to disease-specific PET 
tracers for better characterization of disease expression
20
. The proposed enhanced Dixon 
MRAC combines bone segmentation from high-resolution 3D T1-weighted anatomical 
images, routinely acquired in brain imaging, with the standard Dixon MRAC method 
implemented by the manufacturer. Comparison between the Dixon and enhanced Dixon 
method was made across a number of brain regions to assess regional differences and 
performance. 
 
4.2 Materials and Methods 
4.2.1 Participants 
 This study was approved by the University Research Ethics Board, and written 
informed consent was obtained from all subjects. PET-MRI images were acquired from 
oncology patients recruited following the completion of a clinical PET-CT exam as part 
of their healthcare management. A total of 13 oncology patients were recruited 7 males 
and 6 females (58 ± 8 years old). All subjects had no history of neurological disorder and 
no radiation therapy or chemotherapy prior to imaging and were referred for whole-body 
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PET-CT exam for staging of oncology. To minimize errors in MRI image quality from 
potential image artifacts produced by metal implants such as MR signal loss, only 
patients free of metallic implants and fixtures including dental implants were included in 
this study. 
 
4.2.2 PET-MRI image acquisition 
 
 Whole-brain PET and MRI data were acquired simultaneously on a Siemens 
Biograph® mMR system. The PET subsystem consisted of 8 rings of 56 detector blocks, 
each housing 8 x 8 LSO crystals (size = 4 x 4 x 20 mm
3
) coupled to 3 x 3 array of APDs 
producing a transaxial field of view (FOV) of 59.4 cm and an axial FOV of 25.8 cm. The 
3T MRI subsystem is similar to a Siemens 3T Verio with a maximum gradient strength of 
45 mT/m and slew rate of 200 T/m/s, but a reduced bore size of 60 cm. For detailed 
description of the Biograph® mMR specifications cf. Delso et al. 2011
21
. All MR images 
were acquired using a PET-compatible 16-channel phased array head (12-channel) and 
neck (4-channel) radiofrequency (RF) coil.  
 PET-MRI data were acquired immediately following the completion of 20 minute 
whole-body PET-CT imaging and following a 60-minute uptake of a bolus FDG 
intravenous injection (5 MBq/Kg) administered in a dim lit room. All subjects fasted for 
a minimum of 6 hours and had blood glucose level between 4.8 to 5.8 mmol/L. Clinical 
whole-body PET-CT were acquired following standard oncology imaging protocol from 
the level of the eyes to the mid-thigh. A series of MR images were acquired during a 15 
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minute PET list-mode acquisition with subjects in supine position. The MRI data 
included: 
a) Coronal T1-weighted dual-echo 3D VIBE-Dixon for MRI Dixon-based 
attenuation correction of PET data (repetition time (TR) = 3.60ms, echo times 
(TE) =1.23 and 2.46ms, flip angle = 10°, FOV = 500 x 328mm
2
, 128 slices, voxel 
size = 4.1 x 2.6 x 3.1mm
3
, bandwidth = 965 Hz/Px, acceleration factor of 2, and 
total acquisition (TA) = 0.19s) 
22
; 
b) Sagittal T1-weighted 3D magnetization-prepared rapid gradient-echo (MPRAGE) 
sequence (TR/TE: 2000/2.98ms, inversion time (TI) = 900ms, flip angle = 9°, 
FOV = 256 x 256mm
2
, 176 slices, isotropic voxel size = 1.0 mm
3
, bandwidth = 
240 Hz/Px, an acceleration factor of 2 and TA =  4.48min);  
c) Transverse 3D single shot gradient-and-spin-echo (GRASE) pCASL sequence 23 
(TR/TE = 3500/22.76ms, FOV = 240 x 240 mm
2
, 24 slices, voxel size = 3.8 x 3.8 
x 5mm
3
, bandwidth = 2298 Hz/Px, and acceleration factor of 2). The pCASL label 
consisted of 1.5s train of RF pulses applied 9cm below the center of the imaging 
volume with a mean gradient of 0.6 mT/m. Sixty-four label and control pairs were 
acquired after a post-label delay of 1.2 s for TA = 7 min. Two nonselective 
inversion pulses were applied for background suppression during the post-labeling 
delay. Proton density images (M0) were acquired with the pCASL sequences for 
CBF quantification using a TR of 5 s, with no labeling or background suppression 
pulses.  
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4.2.3 MR attenuation map (µ-map) generation and PET image 
reconstruction. 
 
 Two MRAC segmentation methods were used for attenuation correction of the 
PET data: the standard 2-point Dixon method
22
 and 2-point Dixon method plus bone 
segmentation (Dixon+bone), which is described below. The Dixon MRAC µmaps were 
generated online from segmentation of fat and water signals in the in- and out-of-phase 
Dixon images into fat, soft tissue and air/background, as implemented by the 
manufacturer. Linear attenuation coefficients of 0 cm
-1
, 0.086 cm
-1
 and 0.10 cm
-1
 were 
assigned to air, fat and soft tissue, respectively 
22
. Attenuation correction factors for 
hardware including the RF coil and scanning bed were included in the Dixon µ-map. The 
Dixon+bone MRAC µ-maps were generated offline using SPM8 
(http://www.fil.ion.ucl.ac.uk) and in-house MATLAB (2012a, The MathWorks, Natick, 
MA) scripts. This method overlays a bone mask created from bone segmentation of the 
MPRAGE image to a Dixon µ-map and applies a linear attenuation coefficient (µa) of 
0.143cm
-1 9
, the µa value of  bone at 511kev, to the bone mask.  
 The bone mask for each subject was created as follows. 1) The T1-weighted 
MRPAGE dataset was coregistered to the Dixon in-phase image in SPM8 using rigid-
body transformation with a normalized mutual information cost function to place the 
MPRAGE in the same voxel space as the Dixon µ-map. 2) The coregistered MPRAGE 
image set was segmented into gray matter, white matter, cerebrospinal fluid, bone, soft 
tissue and air/background probability tissue maps in native space using the new segment 
function in SPM8 and ICBM Tissue Probabilistic Atlases 
(http://www.loni.usc.edu/ICBM/). The new segment toolbox employs the unified 
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segmentation method 
24
 that combines affine registration to ICBM atlas, bias field 
correction and segmentation within one integrated model. 3) The bone probability map 
was down-sampled to the Dixon images matrix size, smoothed with a 4 mm Gaussian 
filter 
25
 and thresholded for probabilities above 80% to minimize inclusion of non-bone 
signals. 4) The resulting binary image was eroded with morphological filtering and 
connected component analysis using a 3x3x3 voxel size of ones before assigning µa of 
0.143cm
-1
. Erosion was performed to minimize inclusion of non-bone voxels and the size 
of the structure elements were determined after empirical evaluation of bone voxels 
within a region known to have true bone content.  
 Each subject's PET list-mode data were reconstructed using the Siemens e7 tools 
to one image volume 344 x 344 x 127 matrix with an iterative algorithm (ordered-subsets 
expectation maximization: 3 iterations, 21 subsets; 3D Gaussian filter with a full width 
half maximum (FWHM) = 2.0 mm and 2.5 zoom factor) and corrected for decay, dead 
time, scatter and attenuation. The reconstruction was performed twice using either the 
Dixon (PETdx) or the Dixon+bone (PETdxbone) MRAC µ-map.  
 
 
4.2.4 Image Analysis 
 To allow for group comparison between PETdx and PETdxbone, the PET images 
were spatially normalized to the Montreal Neurological Institute (MNI) PET template in 
SPM8 (http://www.fil.ion.ucl.ac.uk) using an affine transformation and non-linear warps, 
and smoothed with a 6-mm FWHM Gaussian filter. The gray matter (GM) probability 
map for each subject was spatially normalized to the T1 MNI template using the unified 
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segment approach in SPM, also smoothed with a 6-mm Gaussian filter, transformed to a 
binary mask at a threshold of 80% and applied to the PETdx and PETdxbone images. 
 The difference between the Dixon+bone and the Dixon MRAC method across the 
brain was computed as the percent relative difference (% RD) in mean activity 
concentration (Bq/ml) in thirteen a priori regions of interest (ROIs). 
100
)(
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RD . ROI brain masks were created using the automated 
anatomical library 
26
 incorporated within WFU PickAtlas toolbox version 3.0 
27
. The 
ROIs were frontal lobe, cingulate gyrus, insula, parietal lobe, temporal lobe, 
hippocampus, amygdala, thalamus, caudate, globus pallidus, putamen, and cerebellum. 
The PETdx and PETdxbone images were scaled by their respective global gray matter mean 
value to allow for voxel-by-voxel comparison between glucose uptake and blood flow, 
and since absolute quantification of PET-FDG with tracer kinetic modeling was not 
feasible in this study and generally not feasible in clinical practice. Regional %RD in 
relative mean activity was also calculated in the scaled PET data (rPET). To investigate 
potential regional differences, the mean values extracted from individual ROIs were 
compared between the two PET data sets using paired t-tests with SPSS 20.0 statistical 
software (IBM Corp. Armonk, NY, USA). Statistical significant differences were set at 
threshold p-value <0.05. 
 pCASL preprocessing was performed with SPM8 and scripts written in 
MATLAB. The pCASL time series were motion corrected, pair-wise subtracted, and 
time-averaged. The mean signal was registered to the MPRAGE images using a rigid-
body transformation and converted to CBF using a single-compartment flow model 
28
. 
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The CBF images were spatially normalized to the MNI template and smoothed using a 
Gaussian filter with a FWHM of 6 mm. A GM mask was applied to the CBF images that 
were normalized by the global mean. To determine the temporal signal-to-noise ratio 
(tSNR) of the perfusion-weighted time series when acquired with a PET-compatible head 
coil, tSNR was calculated for each subject as defined by the mean pixel signal in the 
whole brain relative to the mean pixel standard deviation. 
 Whole brain voxel-by-voxel independent samples t-tests restricted within a GM 
mask were performed on the individual relative images in SPM8 to investigate 
differences between rCBF and rPET images. Statistical significant differences were 
identified for clusters greater than 50 voxels at p <0.05 after correcting for multiple 
comparisons using the False Discovery Rate (FDR). Voxel-by-voxel Pearson correlation 
was conducted on relative images averaged across subjects within the thirteen ROIs to 
correlate rCBF to rPETdx and to rPETdxbone. 
 
4.3 Results 
4.3.1 Study Participants 
 A full description of the study demographics is listed in Table 4.1, including age, 
gender and diagnosis. No neurological lesions or gross neuropathological abnormalities 
were observed on PET-MRI brain images. Images were reviewed by a Board Certified 
Radiologist and Nuclear Medicine physician. Mean and standard deviation of the time 
from FDG injection to PET-MR examinations were 103 ± 11.18 minutes.  
 
 148 
 
Table 4.1: Study Demographics. 
Number Age (years) Gender Primary oncology disease Net Injected Dose (MBq) 
1 62 F SPN 368 
2 55 M SPN 390 
3 39 M Germ Cell (Testicular) 500 
4 64 M SPN 422 
5 62 F SPN 288 
6 62 F SPN 229 
7 54 M SPN 437 
8 51 F SPN 200 
9 56 M SPN 418 
10 65 F Colorectal 337 
11 61 F NSCLC 411 
12 71 M SPN 388 
13 53 M NSCLC 396 
SPN = Solitary Pulmonary Nodule, NSCLC = non-Small cell lung cancer, M= Male, F=Female. 
 
4.3.2 Evaluation of  MRAC methods. 
 An example of Dixon+bone µ-map created by adding bone to a Dixon µ-map 
from a representative subject is displayed in Figure 4.1. A gradual radial increase in 
relative difference between PET images reconstructed with Dixon+bone µ-map compared 
to Dixon µ-map were observed in all subjects. Figure 4.2a, illustrates the typical line 
profile (Figure 4.2b) through the center slice of the brain of one subject when the PETdx 
and PETdxbone images are compared. An increase of 5% in the center to nearly 20% in the 
areas around the cortex was seen.  
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Figure 4.1: Illustration of a Dixon+bone µ-map generated in a representative 
subject. 
 
Images  (A) T1-weighted MPRAGE, (B) bone probability map, (C) Dixon µ-map and (D) 
Dixon+bone µ-map are shown in axial, coronal and sagittal views of a single slice.  
 
 Group mean values and standard deviation of absolute and relative activity in 
PETdx and PETdxbone for whole brain and regions of interest are listed in Table 4.2. Paired 
student t-test showed that the absolute mean activity in PET data reconstructed with 
Dixon+bone µ-map was statistically higher than PET reconstruction with Dixon µ-map in 
all thirteen ROIs. Conversely, lower relative activity was found in rPETdxbone when 
compared to rPETdx in all ROIs except, occipital and cerebellum. These regional 
differences are depicted in Figure 4.3a as the percent relative difference in mean activity 
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between PETdx and PETdxbone, and in Figure 4.3b as the percent relative difference in 
rPETdx and rPETdxbone for all thirteen ROIs.  
Figure 4.2: Line profile 
 
Line profile (A) across the center slice of a map (B) of relative difference (% RD) between PET 
images reconstructed with Dixon and Dixon+bone µ-maps. Images are presented from a 
representative subject.  
 
Figure 4.3: Regions of interest group means percent relative difference (% RD). 
 
%RD in (A) mean activity concentration and (B) mean relative activity between PET signals 
reconstructed with Dixon and Dixon+bone µ-maps. Errors bars represent standard deviation on the 
means. Regions abbreviations: Fro = Frontal, Cng = Cingulate, Ins = Insula, Par = Parietal, Tem = 
Temporal, Hpp = Hippocampus, Amg = Amygdala, Cad = Caudate, Pal = Globus Pallidus, Put = 
Putamen, Occ = Occipital and Ceb = Cerebellum. 
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Table 4.2: Group mean and standard deviation (std) of absolute and relative PETdx 
and PETdxbone activity concentration (kBq/ml) in regions of interest across the 
brain. 
 
Absolute mean activity Relative mean activity 
 PETdx PETdxbone 
 PETdx PETdxbone 
 
Region Mean std mean std T mean std mean Std t 
Frontal 12. 70 2.60 14.12 2.86 15.21 0.96 0.04 0.97 0.03 2.95* 
Cingulate 13.90 2.88 14.88 3.04 17.74 1.06 0.05 1.02 0.05 -22.66 
Insula 13.47 2.35 14.39 2.50 17.08 1.03 0.04 0.99 0.04 -24.74 
Parietal 13.49 2.71 14.91 2.97 16.99 1.03 0.03 1.02 0.03 -0.74* 
Temporal 11.63 2.26 12.84 2.51 15.11 0.88 0.02 0.88 0.02 -2.01* 
Hippocampus 10.35 1.85 10.93 1.97 14.21 0.79 0.05 0.75 0.05 -32.13 
Amygdala 10.42 1.87 11.03 2.01 13.53 0.80 0.07 0.76 0.07 -26.43 
Thalamus 14.11 2.77 14.87 2.92 13.91 1.07 0.06 1.02 0.06 -34.88 
Caduate 11.33 3.10 11.90 3.24 12.47 0.85 0.09 0.81 0.09 -29.34 
Pallidum 14.23 2.66 15.02 2.83 12.93 1.08 0.07 1.03 0.07 -36.10 
Putamen 16.83 3.21 17.91 3.43 14.21 1.28 0.08 1.23 0.08 -31.08 
Occipital 13.18 2.63 14.87 2.95 16.90 1.00 0.06 1.02 0.07 5.74 
Cerebellum 10.68 1.78 11.97 2.03 16.46 0.82 0.08 0.83 0.08 5.36 
Whole brain 13.16 2.56 14.56 2.81 17.82 1.04 0.10 1.07 0.10 3.05* 
Results of paired differences between PETdx and PETdxbone are presented as value of the t-statistic (t), 
where all regional differences met the statistical threshold of p<0.05 except for * where p value >0.05. 
 
4.3.3 Correlations of perfusion to glucose uptake 
 Images of relative CBF, PETdx and PETdxbone averaged across all subjects are 
displayed in Figure 4.4. In general, these group-wise images are similar in appearance. 
On visual inspection, the group-averaged PET data reconstructed with Dixon+bone µ-
map had an apparent higher intensity compared to PET data reconstructed with Dixon µ-
map, particularly around the cortex. An additional difference between the data sets was 
the aliasing artifact observed in the CBF images, which are most visible in distal images. 
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The mean group gray matter CBF was 43.82 ± 4.46 ml/100g/min. The mean tSNR of 
whole brain pCASL signal in gray matter across all subjects was 2.83 ± 1.18. 
 
Figure 4.4: Whole-brain group maps of relative perfusion and relative glucose 
uptake. 
 
Whole-brain group maps from; left to right: pCASL-CBF, FDG-PET reconstructed with Dixon+bone 
MRAC and FDG-PET reconstructed with Dixon MRAC. Spatial blurring seen in the bottom row 
images of the perfusion maps could be minimized with segmented multi-shot 3D GRASE 
acquisitions. 
 
 The average voxel-by-voxel correlation coefficient across whole-brain grey 
matter was r= 0.63 (p<0.001) between rCBF and rPETdx, and r= 0.53 (p<0.001) between 
rCBF and rPETdxbone. The correlation coefficient for each ROI, derived from voxel-wise 
comparison between rCBF and rPETdx and between rCBF and rPETdxbone, are presented 
in Table 4.3 along with corresponding total number of voxels. For the comparison 
between rCBF and rPETdx, moderate-to-high correlations were observed in all ROIs with 
the highest in the caudate and the lowest in the deep-lying structures of the limbic system 
such as the hippocampus and amygdala.  
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Figure 4.5: Whole brain voxel-by-voxel comparison between rCBF and rCMRglc 
 
Comparison between relative cerebral blood flow and relative FDG-PET activity reconstructed with 
Dixon  (A) and Dixon+bone (B) µ-maps. Areas with greater relative perfusion are shown in red while 
areas with greater relative glucose uptake are shown in blue. Statistical differences are set at threshold 
for cluster > 50 voxels, p <0.05 corrected for multiple comparisons with FDR.  
 
 Similar trends were observed between rCBF and rPETdxbone. Results of voxel-by-
voxel independent samples t-test listed on Table 4.4, showed areas of significant increase 
or decrease in relative perfusion compared to relative FDG-PET signals reconstructed 
with Dixon and with Dixon+bone µ-maps for clusters that met the set statistical 
threshold. Maps of statistical differences between rCBF and either rPETdx or PETdxbone -
overlaid on axial slices of a single subject T1-weighted image are displayed in Figure 4.5. 
Regions with higher relative perfusion are marked in red while regions with higher 
relative glucose uptake are marked in blue.  
 154 
 
Table 4.3: Results of voxel-by-voxel Pearson correlation within thirteen regions of 
interest. 
ROI 
ke rCBF vs. rPETdx 
rCBF vs. 
rPETdxbone 
rCBF vs. PET-
CT 
(Cha et al., 
2013) 
Frontal 70169 0.61 0.52 0.41 
Cingulate 7598 0.77 0.76 0.61 
Insula 3541 0.54 0.53 0.63 
Parietal 26845 0.63 0.58 0.5 
Temporal 32962 0.72 0.63 0.67 
Hippocampus 1797 0.43 0.41 -0.26 
Amygdala 414 0.42 0.40 0.087 
Thalamus 2149 0.68 0.68 0.45 
Caudate 1895 0.85 0.85 0.78 
Pallidum 573 0.41 0.41 Not measured 
Putamen 2009 0.48 0.46 0.81 
Occipital 21333 0.82 0.73 0.12 
Cerebellum 21838 0.54 0.46 0.33 
Correlation coefficients (r, p<0.001) are listed for comparisons between relative ASL-CBF and 
relative PET-FDG measurements corrected with Dixon and Dixon+bone µ-maps, and comparisons 
from a previous study using 2D-pCASL sequence and PET-CT. Total number of voxels (ke) within 
each ROI for the MRAC comparisons are included.  
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Table 4.4: Results of independent samples t-test in gray matter comparing rCBF to 
rPET. 
Cluster number 
Cluster 
size 
X y z t-value Anatomical label 
rPETdx > rCBF       
1 431 -22 12 -8 8.67 Left putamen 
2 435 28 8 -6 7.84 Right putamen 
3 1591 16 34 -28 5.38 Right orbital frontal 
4 457 66 -52 -18 4.88 Right inferior temporal 
5 569 26 -14 68 4.26 Right precentral 
6 685 -20 -54 68 4.25 Left postcentral 
7 126 -44 -24 -32 4.23 Left inferior temporal 
8 61 22 -90 -16 4.16 Right occipital 
9 126 20 -54 70 3.71 Right postcentral 
rPETdx < rCBF       
1 1773 0 -22 42 6.91 Left paracentral 
2 7935 62 -34 10 6.90 Right superior temporal 
3 6368 -56 -28 24 6.24 Left inferior parietal 
4 947 -4 42 -4 5.73 Left anterior cingulate 
5 268 4 -74 0 4.92 Right lingual 
6 59 -2 -86 14 4.55 Left cuneus 
7 77 14 -28 6 3.59 Right thalamus 
rPETdxbone > rCBF       
1 650 26 8 -6 7.9 Right putamen 
  -24 6 -6 7.8 Left putamen 
2 1591 16 34 -28 6.10 Right orbital frontal 
3 1332 66 -52 -18 5.71 Right inferior temporal 
  66 -58 6 5.63 Right middle temporal 
4 4373 26 -14 68 5.25 Right precentral 
5 2848 -20 -36 58 5.05 Left postcentral 
6 65 -18 -38 38 4.21 Left cingulate 
7 79 26 -16 -32 4.09 Right parahippocampal 
8 83 4 -34 -12 3.77 Right anterior cingulate 
9 70 20 -6 20 3.61 Right caudate 
10 76 -20 -72 16 3.58 Left precuneus 
rPETdxbone< rCBF       
1 1318 62 -34 12 6.14 Right superior temporal 
  62 -28 2 5.52 Right middle temporal 
2 630 0 -22 44 5.91 Left paracentral 
3 668 -62 -38 48 5.16 Left middle temporal 
4 238 48 10 18 4.88 Right inferior frontal 
5 210 -48 -60 34 4.79 Left angular 
6 72 4 -72 18 4.57 Right cuneus 
7 73 -46 30 4 4.25 Left inferior frontal 
8 82 -44 10 18 4.15 Left insula 
9 186 6 42 -8 3.87 Right medial frontal 
Results of independent samples t-test in gray matter comparing rCBF to rPETdx and comparing rCBF to 
rPETdxbone for clusters > 50 voxels (p<0.05, FDR). MNI coordinates (x, y and z) and corresponding 
anatomical location are included.  
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4.4 Discussion  
 The feasibility of an integrated whole-body PET-MRI system in simultaneous 
acquisition of perfusion MRI and metabolic PET neuroimaging with an enhanced 
attenuation correction method was investigated in this study. Following efforts by other 
groups to minimize errors in PET signal attenuation corrected with MRI
9,13,14,29
, and 
given the lack of consensus on acceptable MRAC methods for bone attenuation
30
, we 
explored a practical workaround for MRAC. Regional correlates of relative cerebral 
glucose consumption acquired with FDG-PET, to relative cerebral perfusion acquired 
with pCASL were also explored. In general, a good correlation between perfusion and 
glucose consumption was observed over the entire brain, but regional variability in 
coupling was observed, with the highest correlation in the occipital, and the lowest in the 
striatum structures. 
 Direct segmentation of high resolution T1-weighted MR data into various tissue 
classes for MR attenuation correction of PET have been proposed by Zaidi et al
31
 and 
Wagenknecht et al
32
. Segmentation of voxel intensities were performed with 
sophisticated algorithms that use fuzzy clustering or a priori knowledge of tissue location 
and shape to derive MRAC μ-maps with ~6% maximum absolute relative difference 
compared to ground truth
25,31
. However, these methods are time consuming, require post-
processing algorithms that are not readily available, and in Zaidi et al's method
31
; require 
user intervention to improve bone segmentation. In addition, these proposed approaches 
are sensitive to MR intensity inhomogeneity errors which, when left unaccounted for can 
exacerbate inherent MR signal issues such as partial volume effects and motion artifacts, 
potentially inflating bias in MRAC μ-maps. In this study, bone segmentation of T1-
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weighted data was easily derived with SPM, an automated pipeline routinely used for 
brain segmentation in neuroimaging. For each voxel, the unified segmentation method in 
SPM determines intensity distributions of tissue types using a mixed model cluster 
analysis and spatial priors from a T1-weighted atlas derived from large number of 
subjects
24
. Unlike aforementioned direct segmentation methods, the unified method 
accounts for non-uniformities in intensity distributions, improving segmentation 
accuracy
33
.    
 In general, a ~10% increase in whole brain mean FDG activity corrected with 
Dixon+bone compared to standard Dixon MRAC was observed. A gradual increase in 
mean FDG activity from ~5% in the center to ~20% in the cortex was observed in PET 
data corrected with Dixon+bone compared to the same PET data corrected with just 
Dixon alone, as illustrated in Figure 4.2 for one individual. This finding was consistent 
with a recent study comparing PET images corrected with the standard Dixon method to 
images corrected with Dixon plus bone information derived from individual CT
3
. In this 
study, Andersen et al
3
 reported a 15% difference in mean activity from the center to the 
edge of the brain in PET signal reconstructed with Dixon compared to Dixon plus CT 
bone. Errors caused by not including bone information are more pronounced at the edge 
than the center of the brain as photons from the edge of the brain travel longer average 
path lengths through skull than photons from the center
3
. 
 Regional variability in mean activity between PETdx and PETdxbone was also 
observed in the ROI analysis. Cortical structures such as frontal and temporal lobe had 
significantly higher relative differences than central brain regions such as basal ganglia 
and limbic systems (Figure 4.3a). All thirteen brain regions investigated had statistically 
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significant lower mean activity when reconstructed with the standard Dixon compared to 
the reconstruction with the Dixon plus bone (Table 4.2). Similar regional variability in 
PET-corrected with standard Dixon MRAC compared to CT attenuation maps have 
recently been observed by other groups
4,5
. Scaling the PET images by their global mean 
removed the overall underestimation but resulted in regional over- and under-estimations 
(Figure 4.3b). These regional trends matched results from a previous study
4
 and indicate 
that irrespective of the chosen reference region, cerebellum
4
 or global mean as used in the 
current study, relative PET measurements reconstructed with Dixon still possess MRAC-
related bias, albeit slightly reduced. Although signal normalization to a reference value 
can reduce systemic errors in PET reconstruction, it can inflate regional values 
particularly in cases where group differences actually exist between the reference 
values
34
. This might explain the apparent increase in relative PET activity with standard 
Dixon compared to Dixon+bone (table 4.2) or UTE
4
 in nearly all regions of the brain. 
Altogether, the results are in line with previous studies showing that the addition of bone 
information, either from MRI (UTE/MPRAGE) or CT, to the MRAC maps removes the 
radial bias
3
 and reduces differences in PET signals from ~20 % to 10% when compared 
to the gold standard, CTAC
4,9,11,14
. 
 The clinical significance of incorporating bone attenuation in PET reconstruction 
was highlighted by correlating relative cerebral glucose uptake acquired with FDG-PET 
to relative cerebral perfusion acquired with pCASL across regions in the brain. Recent 
evidence suggest that a pattern of regional distribution of perfusion to glucose 
metabolism exist in healthy brains
19,35,36
 and disruptions to regional blood flow-glucose 
metabolism coupling are potential markers of brain dysfunction
37
. In general, a good 
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correlation between perfusion and glucose uptake was observed in this study over the 
entire brain. Regional variability in relative correlations was found, with the highest 
correlations in the occipital and caudate, and the lowest in the limbic structures regardless 
of the MRAC method used (Table 4.3). However, associations between perfusion and 
PET signals reconstructed with Dixon+bone closely resemble patterns of regional relative 
perfusion to glucose metabolism reported elsewhere, with FDG-PET and PET perfusion 
tracers
18,20,38
, and with FDG-PET and ASL using standalone PET and MRI 
scanners
19,39,35
.  
 When compared to Cha et al
19
, where similar regions were explored with a similar 
pCASL labeling scheme, higher regional correlations of rCBF to rPETdxbone were 
observed in the current study, except in the insula and putamen (Table 4.3). This apparent 
increase (~30%) in regional coupling of perfusion to glucose metabolism is likely a result 
of the improved registration accuracy provided by simultaneous imaging and the 
improved tSNR provided by using a 3D pCASL method
23,40
. The temporal SNR of 3D-
GRASE pCASL was not compromised by the use of a PET-compatible head coil, and the 
mean tSNR reported here was in line with values reported elsewhere
23,40
.  
 Results from voxel-by-voxel t-tests between rCBF and rPET demonstrated 
regions of hyper- or hypo-perfusion not matched to glucose metabolism (Figure 4.5 and 
Table 4.4). These findings, specifically from PET data corrected with Dixon+bone 
MRAC, are in line with previous findings of increased resting perfusion to resting 
metabolism in areas of the brain associated with the default mode network
18,19
, 
suggesting that these brain regions require increased blood flow due to the sustained state 
of arousal
36
. Apparent bias in bone attenuation from standard Dixon MRAC was evident 
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in the comparison between relative perfusion and glucose uptake as demonstrated in 
Figure 4.5 and in comparison to previous studies
19,35,39
. In particular, unexpected 
increases in rCBF were observed in the left paracentral, left inferior parietal and right 
superior temporal gyrus when compared to PETdx. The spatial pattern of these 
differences, notably their occurrence closer to the edge of brain, is suggestive of 
attenuation errors. Indeed, these regions of elevated rCBF were either removed or 
significantly reduced when compared to PETdxbone. 
 It is possible that segmentation errors such as voxel misclassifications in 
Dixon+bone µ-maps could account for some differences in correlations between the 
current study and observations reported elsewhere. Differences in µa for bone assigned to 
MR or CT derived µ-maps, and differences in PET scanner geometry and reconstruction 
parameters including number of iterations, subsets and smoothing kernels could also 
influence final observations. In addition, limitations inherent to pCASL and to PET-FDG 
imaging such as partial voluming, differences in cellular localization of  blood water and 
FDG tracers, and optimal selection of post-labelling delay in ASL with minimal 
compromise to SNR could affect accuracy of regional comparisons (cf. Cha et al
19
). The 
evaluation of Dixon+bone µ-maps would have benefited from comparison to ground truth 
using CT data, which was not feasible in this study. The PET-CT whole body survey 
acquired on all subjects prior to PET-MRI imaging, permitted coverage solely from the 
level of the eyes to the thighs as per clinical protocol, limiting whole brain comparisons. 
As such, absolute and regional performance of the enhanced Dixon µ-maps was not 
evaluated. Over estimation of bone information was observed in the inferior regions of 
the brain and can be seen in the Dixon+bone µ-maps (Figure 4.1) and in the comparisons 
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of PETdxbone to pCASL CBF (Figure 4.5). Regions close to the base of the skull where 
bone anatomy is thin can yield low MR bone signals with MPRAGE
25
 or UTE
4
 
sequences, and these regions are prone to signal misclassification errors in soft 
tissue/bone/air interfaces in areas around the sinuses- an issue that affects most atlas-
based MR-derived attenuation correction methods. Efforts were made to minimize bone 
misclassification by morphological filtering of non-bone voxels. A recent study 
demonstrated that SPM8-based method for generating MRAC is robust with a reported 
accuracy of under 4% when compared to CTAC
29
. The results presented here were in 
good agreement with previous studies, suggesting that these issues had little or no effect 
on the study outcome. This suggests that ASL-CBF imaging could be used to in future 
studies to investigate the relationships between altered brain function and disease-specific 
PET tracers. The regional correlation of pCASL CBF to FDG-PET demonstrated here for 
the first time with simultaneous imaging can be further improved with imaging of 
concurrent uptake of the pCASL and FDG tracer.  
 In general, the agreement between this study and previous studies using CT 
attenuation maps indicate that Dixon attenuation maps enhanced with bone information 
from high resolution T1-weighted images can provide a feasible method for correction of 
PET signal attenuation in PET-MRI neuroimaging. Errors in MRI-derived attenuation 
correction maps including tissue misclassification can be further minimized by methods 
that employ tissue classifiers from CT atlas to better guide segmentation of UTE or 
MPRAGE data
13
.  
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5 Chapter 5 
Conclusions and Future Work 
 
5.1 Summary of Findings 
 This thesis explored the role of cardiovascular disease in advancing pathological 
brain aging using novel neuroimaging techniques. As well as investigated the 
potential neuroprotective benefit of aerobic exercise training performed as part of a 
cardiovascular rehabilitation (CR) program. Magnetic resonance imaging (MRI) 
methods were used to measure gray matter volume (GMV) changes and changes in 
cerebrovascular hemodynamics, specifically CBF and CVR, in a group of coronary 
artery disease patients (CAD). In this final chapter, major findings of the studies 
performed in this thesis are summarized. The clinical relevance of the findings is 
discussed and areas of possible future directions are outlined.  
 
5.1.1 Changes in Brain Structure Associated with Cardiovascular 
Disease 
 Although prior evidence demonstrated decreased brain volume in older adults 
with increased risks for cardiovascular disease
1
, changes in regional brain volume have 
not been previously investigated in individuals diagnosed with cardiovascular disease. 
Chapter 2 describes an exploratory study where regional GMV was compared between 
CAD patients and age-matched controls using voxel-based morphometry, to examine the 
impact of cardiovascular disease on brain structure. CAD patients exhibited decreased 
GMV in the frontal, temporal and parietal lobes, and in the posterior cerebellum. These 
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findings are in line with patterns of brain atrophy previously reported in hypertensive and 
diabetic patients
1
, and support evidence of accelerated cognitive decline in cardiovascular 
disease patients
2
. In general, the results suggest that cardiovascular disease accelerates 
brain aging, affecting regions that are typically stable during normal aging.  
 
5.1.2 Impact of Cardiovascular Disease on Brain Hemodynamics 
 Since CAD is a by-product of atherosclerosis and impaired cerebrovascular 
hemodynamics are associated with markers of atherosclerosis, such as arterial stiffness
3
, 
it follows that brains of CAD patients showing signs of structural decline (chapter 2) 
would also have disruptions in hemodynamics. In chapter 3, cerebrovascular 
hemodynamics (i.e., CBF and CVR) and relationships between hemodynamic changes 
and brain atrophy was studied in the same cohort of CAD patients and controls. 
Continuous measurements of cerebrovascular hemodynamics were performed during 
acquisition of ASL images while subjects breathed room air (baseline) or hypercapnic air 
(6% CO2, 21% O2 and balanced air) for 5 min each. Reduced resting CBF was observed 
in CAD patients in the superior frontal, anterior cingulate, pre-and post-central gyri, and 
superior temporal regions, along with decreased CVR in the anterior cingulate, post 
central and superior temporal regions. These changes were independent of changes in 
brain volume, suggesting that cerebrovascular dysfunction precedes brain atrophy.  
 
5.1.3 Potential Neuroprotective Benefits of Cardiac Rehabilitation 
 Since established exercise-based preventative programs are readily available to 
cardiac patients and a myriad of evidence demonstrates positive effects of exercise
4
, the 
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potential neuroprotective benefits of physical activity on the brains of CAD patients were 
explored. Chapters 2 and 3 describe pre- and post-intervention results from CAD patients 
for whom declines in regional brain volume, CBF and CVR were observed pre-
intervention. The exercise intervention consisted of a moderate intensity aerobic fitness 
training lasting 6 months. Findings of increased brain volume in several regions of the 
brain associated with cognitive control, as well as regions linked to motor coordination, 
showed for the first time, the significance of exercise-based CR programs on brains of 
CAD patients. Equally notable was the discovery of recovery in CBF in the anterior 
cingulate and brain volumes in the superior frontal, superior temporal and posterior 
cerebellum. These findings were in brain regions where a measurable decrease was 
observed before rehabilitation. For instance, a ~33% decrease in CBF was observed at 
baseline in the right anterior cingulate in CAD patients compared to control, while a 
~30% increase in CBF was seen post exercise.  
 
5.1.4 Can CBF Measured with ASL Serve as a Suitable Marker of 
Brain Function 
 Current studies suggest that CBF measured with ASL correlates with cerebral 
glucose consumption (CMRglc) measured with PET-FDG
5–7
, a well established measure 
of brain function, and could serve as suitable alternative to PET-FDG
8
. However these 
studies were performed using separate MRI and PET scanners and, therefore, voxel-wise 
comparison of CBF and CMRglc could be confounded by image registration errors and 
differences in brain physiological state between imaging sessions. Chapter 4 describes 
efforts to correlate ASL-CBF to PET-CMRglc acquired simultaneously on an integrated 
PET and MRI system. Marked regional variations in CBF to CMRglc were observed with 
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the highest associations in the caudate and cingulate and the lowest in the limbic 
structures. All findings were well matched to observations from previous studies, 
suggesting that perfusion and glucose metabolism are well matched, but variable 
distribution of perfusion to glucose metabolism coupling exist in healthy brains.  
 
5.2 Relevance of Findings 
 In this thesis, neuroimaging in cardiovascular disease showed a pattern of brain 
decline that is more severe than changes observed in normal brain aging, but reversible 
with moderate aerobic exercise training. The findings from studies described in this thesis 
bear some clinical relevance. First, the findings challenge the monodisciplinary approach 
currently applied to management of cardiovascular disease in older adults. It is clear that 
the brain is affected from cardiovascular disease, specifically diseases of atherosclerotic 
origin. Individuals with a history of cardiovascular disease or at an increased risk for 
vascular disease are more likely to have stroke and related cerebrovascular disease
9
. If the 
expected increase in population of older adults includes an equal increase in 
cardiovascular disease survivors, a better understanding of the complex interaction 
between cardiovascular dysfunction and brain health is imperative, and will require a 
multidisciplinary approach. The studies in this thesis provide a framework for further 
multidisciplinary investigations, as will be discussed below. Second and more 
importantly, the work presented here emphasizes the clinical significance of exercise-
based CR programs in terms of benefit to both cardio- and cerebrovascular health. In 
Canada, although exercise-based CR programs have been established for over 40 years, 
only 1 in 3 eligible patients participate in CR
10
. A major source for underutilization is the 
 171 
 
lack of physician referral to CR
11
. The work laid out in thesis demonstrates the need for 
further research in current CR delivery models to see if inclusion of cerebrovascular 
health assessment and monitoring can improve overall efficacy of rehabilitation 
programs.   
 
5.3 Future work 
5.3.1 Longitudinal and Epidemiology studies 
 Although the results presented in chapters 2 and 3 provide strong evidence of 
cardiovascular disease effects on cerebrovascular structure and function, the cross-
sectional nature of study design, provides a snapshot at best of cardiac disease effects. 
Longitudinal studies of disease progression may reveal further information of cardiac 
disease contributions to brain dysfunction. For instance, in the Baltimore Longitudinal 
Study of Aging, regional CBF was measured in healthy older adults and treated 
hypertensive patients over a period of 6 years
12
. The study found an accelerated decrease 
in regional CBF in the frontal, anterior cingulate and occipital regions over time, but the 
duration of hypertension only contributed to decreased CBF in the frontal and anterior 
cingulate regions
12
. Another longitudinal study of older adults with cardiovascular 
disease measured diverse domains of cognitive performance using a battery of 
neuropsychological tests, at study entry, 1 year and 3 years later
2
. The study reported 
worsening of cognitive performance across all measured domain, but varied trajectory of 
decline with faster decay for visuospatial skills and smaller relative rate of decline for 
executive function and psychomotor speed
2
. Both studies demonstrate that certain brain 
regions have a greater vulnerability to vascular disease over time. It would be interesting 
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to observe changes in brains of CAD patients over time and examine the disease effects 
as the brain ages.  
 
5.3.2 Exercise  
 The neurovascular benefits of low-moderate intensity exercise programs 
performed over a short period time (few weeks to 6 months) in healthy older adults are 
still being explored. Current knowledge of long-term effects is limited and has only been 
explored in one study, which found that walking at least 72 city blocks a week was 
associated with preserved GM volume 9 years later, but walking more than 72 blocks did 
not incur any added benefit
13
.   Lingering questions on exercise threshold effects, that is 
the minimum exercise duration and intensity required to detect structural and functional 
brain changes, are yet to be clearly addressed. For individuals with cardiovascular 
disease, exercise can be both beneficial or detrimental to cardiovascular health and 
overall well being
14
, particularly when performed in unsupervised environments. In 
addition, standard pharmacological therapies for management of cardiovascular disease 
such as statins, beta-blockers and aspirin, are known to attenuate exercise effects
15
 and 
modulate CBF
16
. An immediate question to address would be: does a single duration of 
exercise training, for instance a 6-month aerobic exercise regimen such as in CR, confer 
long-term neuronal protection for cardiovascular disease patients?   
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5.3.3 Characterizing white matter structure in coronary artery 
disease patients.  
 White matter (WM) lesions are prevalent in individuals with increased risk for 
vascular disease
17
. Cerebral hypoperfusion is thought to significantly impair WM 
connectivity affecting the speed of cognitive processing
18
. In healthy older adults, higher 
cardiorespiratory fitness is associated with preservation of age-related declined in WM 
microstructure
19
. Associations of vascular disease to disruptions in WM structural 
integrity and subsequent effects on cognitive function are unclear. It is quite possible that 
reports of accelerated cognitive decline in cardiovascular disease patients
2
 could be 
linked to disruptions in WM integrity that are related to vascular disease
20
. In the same 
token, improvements in cognitive performance ascribed to exercise training
21
 could be 
mediated by exercise-induced plasticity of WM structure
22
. Therefore, it would be 
interesting to elucidate WM regions vulnerable to cardiovascular disease, investigate 
relationships of WM abnormalities to cognitive impairments, and explore the role of CR 
in mediating disease effects on WM microstructure.   
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Appendices 
 
Appendix A: An Overview of the Optimized VBM approach as implemented in 
SPM8 
 
Figure A1 : Flow chart of optimized VBM as implemented in SPM8. 
 
 
 In optimized VBM
1
 [1], the original T1 image volume in native space is 
segmented into GM and WM images, followed by the removal of unconnected non-brain 
voxels in skin, skull and dura from the segmented images using fully automated 
morphological operations (erosion and conditional dilation). [2] The resulting GM and 
WM images are spatially normalized to GM/WM templates further eliminating 
contributions of non-brain voxels and improving spatial normalization of GM/WM 
images. [3] The normalization parameters are then applied to the original T1 image 
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volume placing the images in stereotactic standard space. [4] Subsequent segmentation of 
the normalized T1 images into GM, WM and CSF partitions is performed to generate a 
GM concentration map. [5] Spatial smoothing is applied to the GM map by convolving 
the images with an isotropic Gaussian kernel. This renders the data more normally 
distributed and compensates for the inexact nature of the spatial normalization. [6] 
Finally, a generalized linear model fit is applied to the smoothed GM images for group 
comparisons or correlations with covariates of interest.  
 Alternatively, segmented GM images in spatial correspondence to the template 
can be [4a] multiplied ("modulated") by the Jacobian determinant derived from the 
spatial normalization step [2]. This compensates for the non-linear effect of spatial 
normalization and preserves the total amount of GM in the normalized data
1
. Individual 
variations in brain sizes can be accounted for by either including the total intracranial 
volume, which is the sum of GM, WM, and CSF, as covariates of no interest during the 
statistical model fit (i.e. global normalization), or by modulating only the non-linear 
components of the Jacobian determinant, which is recommended (dbm.neuro.uni-
jena.de/vbm/). Hence, unmodulated smoothed normalized GM images represent relative 
concentration of GM while modulated smoothed normalized GM images can represent 
absolute volume of GM or relative volume corrected for differences in brain sizes. In 
chapter 2 and 3, absolute GM volumes corrected for differences in brain sizes were used 
to investigate regional differences in brain structure. 
 To improve signal-to-noise ratio and the sensitivity of detecting local changes in 
gray matter, the T1 images are bias corrected for image intensity non-uniformity prior to 
segmentation and the resultant GM volume or concentration maps are smoothed by 
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convolving the images with an isotropic Gaussian kernel. Bias correction accounts for the 
smooth intensity variations due to spatially-dependent response of the head receiver coils. 
While spatial smoothing renders the data more normally distributed and compensates for 
the inexact nature of the spatial normalization. However, since spatial smoothing can blur 
an image minimizing the ability to detect local changes, the size of the Gaussian kernel 
should match the size of the expected effect.  
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